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A new microdialysis sampling method and microfluidic device were developed in vitro. The method 
consisted of using up to four microdialysis sampling probes connected in series to evaluate the relative 
recovery (RR) of different model solutes methyl orange, fluorescein isothiocyanate (FITC)-dextran average 
mol. wt. 4,000 (FITC-4), FITC-10, FITC-20, and FITC-40.  Different flow rates (0.8, 1.0, and 1.5 µL/min) 
were used to compare experimentally observed relative recoveries with theoretical estimations. With 
increasing the number of probes in series, the relative recovery increases and ~100% (99.7% ± 0.9%) 
relative recovery for methyl orange was obtained.  For larger molecules such as fluorescein isothiocyanate 
(FITC)-dextran average mol. wt. 4,000 (FITC-4), FITC-10, FITC-20, and FITC-40, RR of 66.3% ± 0.0%, 
39.4% ± 0.6%, 18.7% ± 0.1%, and 7.7% ± 0.1%, respectively, were obtained using four microdialysis 
sampling probes in series at 0.8 µL/min.  Using theoretical estimations, the number of microdialysis probes 
in series needed to achieve 99% RR was determined for each solute. The theoretical estimations started 
deviating from experiments at mol. wt. 10,000 (FITC-10). For example, the deviations from experiments for 
FITC-10, FITC-20, and FITC-40 were +52%, +149%, and +179% respectively. On the other hand, methyl 
orange and FITC-4 theoretical estimations were closer to the experiments (-1%, underestimation, and 
+15%, overestimation). The method developed for this dissertation was miniaturized in a 
polydimethylsiloxane (PDMS) microfluidic device having a flat polyethersulfone membrane and seven 
micro-channels connected in series. Push-pull experiments determined that the optimal setting for this 
microfluidic device prototype during the collection of methyl orange was 0.2 µL/min-1.0 µL/min. The relative 
recovery of methyl orange using this setting was 78.8% ± 2.5%. This result indicated that a working 
microfluidic device prototype was developed. Further optimizations need to be performed to reach the same 
level as the microdialysis probes in series method. All the work conducted to achieve the development and 
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Dq Diffusion coefficient in the quiescent medium 
𝑓 Friction factor for fully developed laminar flow in noncircular pipes 




K Apparent diffusion constant across the membrane 
k mass transfer coefficient 
L Microchannel length 
Lm Effective membrane length 
P Overall probe-external medium permeability 
Q Flow rate 
Qd/ Qin Flow rate of the perfusion fluid 
Qout Flow rate of the dialysate 
ΔP Pressure drop  
+ΔP Positive pressure difference 
−ΔP Negative pressure difference 
Δ𝑝𝑎 Pressure drop within the annulus fluid 
ℜ𝑎 Annulus hydraulic resistance  
𝑟𝑐𝑎𝑛𝑛 Outer radius of the cannula 
𝑟𝑖 Membrane inner radius 
Rd Mass transport resistance of the dialysate 
Re Reynolds number 
Rm Mass transport resistance of the microdialysis probe membrane 
Rq Mass transport resistance of the quiescent medium external to the microdialysis probe 
𝑟𝑜 
Membrane outer radius  
S/A 
Surface area of the microdialysis probe membrane 
𝒮𝓂 






Perfusate viscosity  
𝜍 
Annulus radius ratio 
𝑉𝑎𝑣𝑔 




1 Chapter 1. Introduction to microdialysis sampling and microfluidic devices 
 Microdialysis sampling  
1.1.1 History 
Microdialysis sampling is a diffusion-based separation technique commonly used to sample 
biomolecules from fluid compartments (Figure 1.1) in mammals such as humans,1, 2 monkeys,3, 4 rodents,5 
and pigs.6, 7 Microdialysis probes are composed of a concentric semi-permeable membrane, outer support 
membrane layer, inner cannula, and inlet and outlet tubing, see Figure 1.2. Microdialysis samples the 
extracellular fluid (ECF) or the fluid between the cells, because this is where chemical transport and 
chemical communication occurs. Proteins, electrolytes, and other chemicals travel in this region and are 
able to be collected during microdialysis sampling experiments.8 The intracellular fluid (ICF), on the other 
hand, is the fluid inside the cell enclosed by plasma membranes. This region is closely regulated by the 
body and makes up ~60% of the total water in the human body.8 The amount of water present in the human 
body varies depending on the type tissue from 8% in the teeth to 80-85% in the brain.8 Microdialysis 
sampling has been widely used to collect many different classes of molecules from extracellular fluid (ECF) 
space with more than 15,000 publications documenting the collection of various solutes of biomedical  
interest.9, 10 Like many separation techniques microdialysis sampling went through an evolutionary usage 





















Figure 1.2. Schematic representation of traditional microdialysis sampling experiment setup. 
 
Prior to microdialysis sampling, push-pull technique and dialysis bags were the preferred methods 
to collect biomolecules from living systems. Briefly, push-pull technique consists of pushing a solution 
through a cannula into a sampling site and pulling the solution by an adjacent cannula.12 Push-pull 
technique fell out favor due to the fact that it was difficult to operate and caused a significant amount of 
tissue damage.12 In 1966 Bito et al. were the first to propose the use of dialysis bags, sometimes called 
sacs for the collection of biomolecules from the brain of dogs.9, 12, 13 One of the problems with this approach 
was that you could only take one sample per dialysis bag implanted.13 Moreover, these dialysis bags were 
implanted for more than two months in order to study concentration changes of the biomolecules of 
interest.12 As it is well-known, longer implantation periods lead to encapsulation of any implanted device by 
living systems foreign body response, when the immune system is unable to destroy it and try to isolate 
it.14, 15 Foreign body response is outside of the scope of this dissertation and it is not going to be addressed 
in detail here.  
Another improvement towards to what we nowadays called microdialysis sampling was 
demonstrated by Delgado et al. six years later (1972). Delgado and colleagues further developed the 
dialysis bag technique and called it dialytrode.9, 13, 16 The dialytrode worked by perfusing a solution into a 
dialysis bag and moving it to an area where it could be collected and analyzed.9 This process mirrored 
today’s microdialysis sampling in which a solution is infused into a microdialysis probe and then collected 




Finally, Ungerstedt et al. replaced the dialysis bags with hollow fibers and successfully measured 
neurochemicals in the brain of rats.9, 12 Since then, microdialysis sampling became the preferred sampling 
technique to study biomolecules in living systems.  
Commercially available microdialysis probes, as shown on Figure 1.3, consist of two fluorinated 
ethylene propylene (FEP) pieces of tubing (inlet and outlet) and a cylindrical hollow fiber semipermeable 
membrane of 0.5 mm in diameter. Semipermeable membranes are typically made of either 
polyarylethersulfone (PAES) or polyethersulfone (PES). Other materials such as polycarbonate/polyether 
(PC), polyamide17 and cellulose acetate are used as microdialysis probe membranes as well. Microdialysis 
probes of different membrane lengths to sample from subcutaneous (10 mm) and brain (4 mm) spaces can 
be purchased from different vendors.18 Also, microdialysis probes having membranes of different molecular 

















As previously mentioned, microdialysis sampling is a diffusion-based separation technique. 
Traditionally, microdialysis experiments require a microdialysis probe, gas-tight syringe, syringe pump, and 
perfusion fluid (Figure 1.2). During microdialysis sampling the perfusion fluid or perfusate is selected so 
that its chemical composition matches the chemical properties of their milieu (ECF) such as a pH and ionic 
strength.19 Matching the chemical properties of the perfusion fluid to the environment in which it is perfused 
in is important to avoid disrupting the biology of the collection site or tissue.  
Microdialysis sampling experiments can be conducted either in vivo or in vitro. In vitro microdialysis 
sampling experiments are conducted to gain information about the efficiency of the microdialysis probes 
and transport behavior of biomolecules. For example, microdialysis sampling has been used in vitro to 
sample peptides and proteins in highly complex bioprocesses.20 However, most application are conducted 
in vivo. During in vivo microdialysis the sampling site is a living system’s fluid compartment (e.g. ECF). On 
the other hand, the sampling site during in vitro microdialysis sampling experiments is a synthetic reservoir 
aimed to mimic the physicochemical conditions of living system’s fluid compartments. In some cases, a 
small plastic vial or any other reservoir is used as sampling site. This causes several issues when 
correlating in vitro experiments to in vivo since the concentration of analyte in fluid compartments is never 
precisely known and can change rapidly overtime. Moreover, the tortuous path that biomolecules diffuse 
through during in vivo collections is significantly larger than in vitro collections, see Figure 1.4.21 A new 
approach in which several or four microdialysis sampling probes are connected in series was developed 
for this dissertation. This microdialysis in series approach seeks to address the problem of never knowing 
the concentration of analyte in fluid compartments by getting to an equilibrium concentration as the surface 
area of the microdialysis probe increases as well as the residence time. This issue will be addressed in 
more detail later in the chapter.  
The main driving forces acting on microdialysis sampling technique are hydraulic and concentration 
gradient. In order to create a hydraulic force during microdialysis sampling, a positive pressure (flow rate) 
is generated by a pump, typically a syringe pump. The flow rate generated by the syringe pump must be 





















Figure 1.4. Comparison of in vivo and in vitro diffusion pathways during microdialysis sampling.21 Adapted 
from reference 21, Copyright 2017, with permission from Elsevier. 
 
The pressure at the outlet tubing is atmospheric (1 atm), since the outlet is open to the room where 
experiments are conducted. The resultant of pressure difference (ΔP) generated during microdialysis 
sampling experiments is called flow rate (Q). Flow rate represents the amount of volume that travels in the 
tubing as a function of time and its units are volume/time (µL/min). This is much like electric current which 
represents the amount of electric charge flowing in an electric circuit when a voltage difference in generated. 
Engineers take advantage of the latter to study flow behavior using electric circuits. This is very useful for 
prototyping. The mathematical approach used to accomplish this is called equivalent circuit theory.22 
The pressure difference is typically positive (+ΔP) in traditional microdialysis, or negative (-ΔP), 
push-pull and vacuum ultrafiltration. It is good to point out that a +ΔP can be generated during push-pull 
microdialysis, but not during vacuum ultrafiltration, see Figure 1.5. As stated on section 1.1.1, the push-pull 
perfusion technique was one of the first microdialysis sampling techniques developed. The technique 
consists of pushing a solution through a cannula into a sampling site and pulling the solution by an adjacent 
cannula.12 One of the problems with this technique was that it causes a significant amount of tissue damage 














Figure 1.5. Schematic representation of pressure profile along microdialysis probe.23 (a) push; (b) pull; (c) 
push and pull. Adapted from reference 23, Copyright 2017, with permission from Elsevier. 
 
 In contrast, push-pull microdialysis was developed to eliminate fluid loss. In push-pull microdialysis 
technique the perfusion fluid is normally pushed at a lower pressure into the inlet of the microdialysis probe 
and pulled at a higher pressure from the outlet (dialysate). The negative pressure difference ensures that 
the perfusion fluid is not loss across the microdialysis probe membrane. According to Polak, “push-pull was 
the most effective method for the elimination of fluid loss or gain during the sampling by probes of high 
MWCO [e.g. 100 kDa].”24 On other hand, microdialysis sampling probes of 15 kDa MWCO or smaller were 
not influenced by pumping methods.24 This could be due to the fact that membranes of smaller pore size 
are least susceptible to imbalance between the hydrostatic and osmotic pressure or fluid loss due to osmotic 
flux.25 
Normally, during a microdialysis sampling experiment the perfusion fluid lacks the analyte of 
interests. This type of experiment is called relative recovery experiment. A concentration gradient is 
generated across the microdialysis probe membrane, during this experiment, and analytes diffuse from 




To explain, the solution located outside the microdialysis probe membrane must have a higher 
concentration than the perfusion fluid located inside the microdialysis probe membrane. This allows the 
target biomolecules to diffuse from outside of the membrane to the inside and be carried by the perfusate 
to the microdialysis sampling probe outlet. The solution composed of perfusate and analyte is called 
dialysate. The dialysate is the solution that is collected and analyzed during microdialysis sampling 
experiments, see Figure 1.6. Unlike the perfusion fluid, the dialysate contains the analyte of interest during 
microdialysis sampling collections. On the other hand, during pharmacokinetic studies, for example, in 
which drugs need to be delivered in situ to study their interactions with their milieu, the perfusate 
concentration is not zero. This microdialysis sampling mode is called delivery. Delivery is essentially the 
reverse process of collection mode.  
The efficiency of microdialysis sampling is represented as either relative recovery (RR) or extraction 
efficiency (EE).26, 27 Relative recovery is defined as the ratio of dialysate concentration or outlet 
concentration (Coutlet) and the concentration of the analyte far away from the collection point (Csample,∞).27 



















Relative recovery can also be expressed as: 28  
RR = 1 − exp {
−1
Qd(Rd+Rm+Rq)
}                                      Equation 1.2 
The terms of equation 1.2 have been defined in detail by Bungay et al. as shown in Figure 1.7.29 In Equation 
1.2, Qd  represents flow rate, Rq  mass transport resistance of the quiescent medium external to the 
microdialysis probe, Rd mass transport resistance of the dialysate, and Rm mass transport resistance of the 
microdialysis probe membrane. The difference between Equation 1.1 and Equation 1.2 is that Equation 2 
includes the resistances involve in the microdialysis sampling process and its flow rate. These resistances 








Figure 1.7. Bungay microdialysis sampling mass transport model and strategies to minimize the influence 
of mass transport resistances on the relative recovery (RR).26, 29 
 
Equation 1.1 is more commonly used during microdialysis sampling experiments. For experiments in which 
a deeper understanding of the sampling site is needed, Equation 1.2 is used. However, the resistance 
values are often hard to get. Equation 1.2 is mostly used for microdialysis sampling modeling and theoretical 
work. Relative recovery differs from absolute recovery or recovery, a term commonly used in analytical 
chemistry separation processes, in that the relative recovery is concentration based and absolute recovery 










Figure 1.8. Relationship between relative recovery, absolute recovery, and flow rate.12 (Redrawn from 
reference 12) 
 
As the flow rate increases more mass overall is collected, absolute recovery, but a larger volume and 
smaller mass of analyte or lower concentration relative to the concentration outside the membrane is 
collected (relative recovery). Relative recovery is commonly used during microdialysis experiments, 
because the concentration of analyte outside the membrane is unknown during in vivo experiments. 
Sometimes this causes confusion among researchers that are not familiar with microdialysis sampling 
relative recovery. Figure 1.7 illustrates that the resistances denoted in this equation depend on the effective 
membrane length (L), which in terms is directly related to relative recovery. This means that a microdialysis 
probe with a membrane of large surface area will have a higher relative recovery than a probe with a 
membrane of small surface area (all other parameters being equal). The membrane length is a key feature 
useful to reduce the influence of resistances on relative recovery. Microdialysis sampling technique has 
several advantages and drawbacks as shown in Table 1.1, modified from the Kloft and Plock’s review about 











 Calibration methods 
A common issue that continues to frustrate many microdialysis sampling users is that of in vivo 
calibration. There are numerous reasons why calibration of implanted microdialysis probes in vivo is 
extremely challenging. The primary reason for this has been recognized for decades is that tissues are not 
homogeneous structures and there are typically numerous inputs and outputs that can be difficult to model 
in vitro.31, 32 In vivo microdialysis calibration methods have different problems associated with their use and 
in many cases can be quite cumbersome from an experimental perspective. It is good to point out that the 
term calibration in this context means to determine the concentration of the target analyte outside the probe 
or from the sampling site. This cannot be confused with the more commonly used definition of calibration, 
in which instruments must go through during experiments. These calibration methods used for in vivo 
calibration require steady-state concentrations for measurements.33 
1.2.1 In vitro 
The first calibration method used to correlate Coutlet to Csample,∞ was the in vitro calibration method.34 
The way how in vitro calibration method works is by determining the concentration (relative recovery) of a 
standard solution of the biomolecule of interest in vitro and relating it to the in vivo relative recovery.12  
Advantages Drawbacks 
Collection of biomolecules at site of action Size limitation for molecules of interest 
Direct delivery to target tissue Determination of mean concentrations overtime interval 
On-line measurements Calibration necessary as recovery does not reach 100% 
“Analytically clean” samples 
Requires an analytical method with a low limit of 
quantitation capable of dealing with small volumes 
Simultaneous sampling at multiple sites Risk of tissue trauma 9 
Applicability to almost every organ Limited time resolution ≥1 min; typically 10 min 9 




This method assumes that the mass transport resistance of the membrane is greatest through the 
membrane and not the tissue.34 The problem with this assumption is that, as stated before, the tortuosity 
of in vitro experiments is almost non-existence compared to in vivo experiments. Nevertheless, the kinetic 
processes that drive the differences between in vivo and in vitro calibration are similar. 
Another problem with this method and that few researchers have addressed, is that the pressure 
inside sampling sites (in vivo) is not constant, see Figure 1.9. Every time a microdialysis probe is implanted 
in any tissue the transmembrane pressure of the semipermeable membrane will increase. For example, 
the pressure in the cranium of humans or intracranial pressure can vary from 2 to 7 mmHg in healthy 
patients. The intracranial pressure of injured patients can be more than 50 mmHg.35 Still several factors 
such as age, body posture, and clinical conditions can affect intracranial pressure.36, 37  
This is far different than collections conducted in vitro in which only atmospheric pressure is present outside 
the microdialysis probe membrane. When the in vitro calibration method is used the relative recovery of the 















Figure 1.9.Variation of pressures within the human body.37 (From reference 37 with permission from the 
Creative Commons Attribution License, open access, see appendices)  
 
1.2.2 No-net flux or zero-net-flux 
The method of zero-net-flux method requires steady-state concentrations and if they are present 




This method requires a significant amount of experimental time to cycle through the concentrations 
necessary to straddle the suspected in vivo concentration. According to Hershey and Kennedy, no-net-flux 
is the most popular calibration method for in vivo microdialysis sampling experiments.39 However, this 
method requires steady-state conditions and not all analytes are at steady-state during experiments. 
1.2.3 Internal standards 
The internal standards calibration method requires steady-state conditions as the no-net-flux 
method.34 Stable-isotope labels or other suitable analogs for small molecules are used for this method, but 
can be problematic or prohibitively expensive for different solutes including drugs, peptides and proteins. 
1.2.4 Slow perfusion 
Like its name implies, the slow perfusion microdialysis sampling calibration method consists of the 




 . The slower the flow rate used, the higher the residence time of the perfusate. Higher residence 
times allow the perfusion fluid more time to interact with the fluid surrounding the microdialysis probe 
membrane. Hence, more time for the analyte to travel from outside the membrane into the perfusion fluid 
(inside the membrane). The aim of this method is to allow enough time for equilibrium to occur between the 
perfusion fluid and the fluid surrounding the microdialysis probe membrane. One of the problems with the 
slow perfusion method is that it requires very long collection times in order collect enough sample (e.g. 50 
µL for some ELISA kits) to analyze it. Long collection times lead to sample evaporation.   
 Membranes 
Another limitation of microdialysis sampling is that the relative size of semipermeable membrane 
pores is expressed as molecular weight cutoff (MWCO). Molecular weight cutoff is one of the factors that 
influence the relative recovery of biomolecules, according to Chaurasia (Table 1.2).38 Snyder et al. stated 
that as the size of the analyte approaches to the size of the microdialysis probe pore size a reduction in the 
relative recovery of the analyte is observed due to an increase in the microdialysis membrane resistance.40 
The latter as compared with smaller analytes.40 MWCO allows researchers to choose microdialysis probes 




However, there are several issues with using MWCO as an indication of the pore size of microdialysis probe 
membranes. First of all, there is not a standardized method to determine MWCO of semipermeable 
microdialysis probe membranes. Some companies do not disclose which method they use, and methods 
can vary from company to company.41, 42, 43, 44 One method used to determine MWCO of microdialysis probe 
membranes is equilibrium dialysis, in which a semipermeable membrane is placed in between two enclosed 
chambers.22 The membrane serves as a barrier to separate both chambers. Several chemical compounds 
of different molecular weights are placed in one chamber and the other chamber is filled with a buffer 
solution. This is done to generate a concentration gradient across the membrane “similar” to the 
microdialysis collection mode previously mentioned. Next, the enclosed chambers are incubated until 
equilibrium is reached.42 The problem with using this method to determine MWCO of microdialysis probe 
membranes is that microdialysis sampling works differently than equilibrium dialysis.  
 
 
Table 1.2. Chaurasia’s list of factors influencing microdialysis sampling recovery.38 
 
1) Perfusion flow rate 
2) Sample flow rate 
3) Temperature of the tissue or dialysis target 
4) Diffusion of the substance within the sample medium  
5) Diffusion rate in dialysis membrane 
6) Molecular weight cutoff of the dialysis 
7) Chemical interaction between the analyte and the membrane 
8) Surface area of the dialysis membrane (length and diameter of the probe) 
9) Blood flow rate 
10) Metabolism rate 
11) Uptake into cells 





Microdialysis sampling is a dynamic process driven mainly by pressure differences or flow rates in 
which a perfusion fluid is continually being perfused, so equilibrium is never reached between inner and 
outer compartments of microdialysis probe membranes.42, 45 Some companies define MWCO as the 
molecular weight of a molecule that is 90% retained by the membrane or 90% of the total molecules that 
diffuses across the membrane.41, 43, 44 Depending on the company the percentage of retention can oscillate 
from 60 to 90%.41, 44 Several approaches are used by researchers and companies to minimize this problem. 
For example, Li and Cui stated that, “Theoretically, the MWCO of microdialysis membrane three times 
greater than the molecular weight of the target molecule is sufficient to permit diffusion across  the dialysis 
membrane.”46 This approach ensures that, on average, membrane pores are larger than target molecules. 
In contrast, CMA Microdialysis A Harvard Apparatus Company advises to choose a microdialysis probe 
membrane four times greater than the molecule of interest.47 Another example, Bioanalytical Systems, Inc 
(BASi) claims on their tech note 1013 that their microdialysis probes have a molecular weight cutoff range 
of 30 to 38 kDa (kilodaltons), but during microdialysis experiments they would not expect to collect any 
chemical compounds higher than 6 to 7 kDa.42 Compared to the other two examples, BASi would 
recommend to choose microdialysis probes five times greater than the analyte to be sampled. As can be 
seen there is not a consensus on what molecular weight cutoff really means adding more complexity to 
microdialysis sampling experiments. The ultimate goal would be to have a more robust microdialysis 
sampling probe with a minimal membrane transport resistance for analytes of different molecular weights. 
 Mathematical models 
Many biomolecules have their concentrations changed during disease states. Microdialysis 
sampling technique allows researchers to monitor those changes in real-time. However, as mentioned 
before, microdialysis calibration methods can only give an approximate value of the concentration. For 
example, knowing the concentration of glucose is vitally important for people suffering from diabetes. This 
information facilities physicians regulate their glucose levels.  
Several attempts to solve this problem have been made utilizing different strategies, see Table 1.3.9, 21 
According to Kehr, the first researchers to identify and try to quantify relative recovery during microdialysis 




Their method assumes that microdialysis sampling in vitro recoveries, under quiescent conditions, were the 
same as in vivo recoveries.21 This would allow them to determine the relative recovery of different 
biomolecules present in different tissue spaces. Their idea was that, if you used the same conditions 
(microdialysis sampling probe and flow rate) used to determine recoveries in vitro, when used in vivo they 
must be equivalent. However, there are a lot of problems with their assumption.9 Some these problems 
were previously addressed in this chapter. 
Firstly, the concentration of biomolecules is generally not static in living systems, they change 
rapidly which is not the case for in vitro microdialysis experiments. However, some studies have found that 
for some concentrations those changes are generally static and stable for long periods of time. Another 
problem, as stated before, is that the tortuosity for in vivo microdialysis is significantly different than in vitro, 
see Figure 1.4.  
 









Benveniste et al. determined that microdialysis sampling recoveries of potassium (K+) and calcium 
(Ca2+) ions in vitro  were higher than those measured in vivo.31 They used ion-selective microelectrodes in 
order to measure the ions concentration in the dialysate.  
Type of model Author (s) Year (s) 
Empirical 





Merlo Pich 1993 
Mathematical 
Lindefors and Amberg 1989 
Benveniste et al. 1989, 1990 





Due to this observation a tortuosity factor, λ, was introduced to correct for the difference in tortuosity for in 
vivo and in vitro microdialysis experiments.31 This factor was defined by Nicholson and Philips in 1981 and 




                                                          Equation 1.3 
Where λ represents the tortuosity factor, Dq is the diffusion coefficient in the quiescent medium, and De the 
diffusion coefficient in the extracellular space. Benveniste and colleagues strategy worked well for 
microdialysis sampling collections of Ca2+, but not so well for neurotransmitters such as glutamate and 
dopamine.31  
An empirical method called flow rate method was developed by Jacobson et al. in 1985, see Figure 
1.10.9, 50, 51 According to Chefer et al.,“The flow rate method was one of the first empirical methods designed 
to determine extracellular concentration by determining the relationship between perfusate flow rate, the 
active area of the membrane, and the mass transfer coefficient and then extrapolating to the case of zero 
flow rate.”9 Jacobson et al. pointed out that the mass transfer coefficient (k) of any molecule can be 
determined experimentally during microdialysis sampling by measuring its relative recovery at different flow 
rates and plotting the results to find the slope or k, see Figure 1.10.50, 51 Bungay et al., stated that the overall 




Rd + Rm + Rq
                                              Equation 1.4 
In Equation 1.4, S or A is surface area of the microdialysis probe membrane, Rq mass transport 
resistance of the quiescent medium external to the microdialysis probe, Rd mass transport resistance of 
the dialysate, and Rm mass transport resistance of the membrane, see Figure 1.7. To determine the mass 
transfer coefficient, k, of any biomolecule using microdialysis sampling technique, Equation 1.2 and 1.4 are 
combined: 
RR = 1 − exp {
−1
Qd(Rd+Rm+Rq)







)                                        Equation 1.4 
Note that in Equation 1.4 P and S were replaced by k and A. 
Thus: 
RR = 1 − exp (
−𝑘A
Qd
)                                      Equation 1.5 
Rearranging Equation 1.5: 
𝑘𝐴 = [−ln(1 − RR)]Qd                                   Equation 1.6 


















Figure 1.10. Jacobson et al. microdialysis sampling method.50, 51 Reprinted from reference 51, Copyright 
2017, with permission from Elsevier. Original figure reference 50, Copyright 2017, with permission from 
Elsevier. 
 
By plotting –ln (1 − RR) as a function of Qd-1, the product kA can be obtained from the slope, see 




Most microdialysis sampling mathematical methods make this assumption. This method was used to 
estimate the relative recovery of methyl orange and fluorescein isothiocyanate-dextrans (FITCs) during 
microdialysis probes in series approach as denoted in chapter 4.  
 Approaches to improve relative recovery  
Microdialysis sampling relative recovery is a multifactorial problem which makes it a challenging 
problem. Chaurasia listed a number of factors such as flow rate, temperature, diffusion properties, 
molecular weight cutoff, and so on that influence the relative recovery of biomolecules during microdialysis 
sampling, see Table 1.3.38 Researchers have developed several strategies to improve the collection of 
biomolecules such as cytokines using microdialysis sampling.27, 52, 53  
1.5.1 Affinity agents 
Duo et al. developed a method to improve cytokine relative recovery using affinity agents such as 
antibodies and heparin attached to polystyrene microspheres, see Figure 1.11.53 Their method consists in 
perfusing polystyrene microspheres with affinity agents chemically attached to their surface. For example, 
they chemically attached antibodies to the surface of the microspheres and perfused them through the 
microdialysis probe during cytokines collection to increase cytokines diffusion across the membrane 
pores.53, 54 Finally, cyclic oligosaccharides called cyclodextrins have also been used as affinity agents to 
improve microdialysis relative recovery of molecules.55 
1.5.2 Mechanical approaches 
 Recycling or recirculation 
Another way to improve the relative recovery of biomolecules during microdialysis sampling 
experiments is by increasing the residence time of the perfusion fluid at the microdialysis probe 
semipermeable membrane (inner site). As mentioned before this can be achieved by using slow flow rates; 
however, several issues arise when slow flow rates (< 0.5 µL/min)56, 57 alone are used. Some of these 













Figure 1.11. Microdialysis sampling using affinity agents approach.53 Reprinted from reference 53, 
Copyright 2017, with permission from Elsevier. 
  
 
Figure 1.7 shows that from a theoretical stand point increasing the surface area and length of the 
microdialysis sampling membrane will improve relative recovery. The problem with increasing the length of 
microdialysis probe membranes is that you are limited by the size of the sampling site. In other words, 
extracellular fluid compartments in living systems are very small relative to the current microdialysis 
sampling probes. Microdialysis sampling probe membranes of 4 or 10 mm in length are commonly used. 
However, depending on the need smaller membranes (1 mm) can be used. In general, the size of the 
sampling site dictates the length of the microdialysis probe membrane. 
In 1986 Lerma et al. were the first to design a microdialysis sampling probe having a closed loop 
to recirculate perfusate (Figure 1.12) for in vivo measurements of amino acids in rat hippocampus.58 They 
used this method to increase the residence time of the perfusate and predict the concentration of amino 
acids in the extracellular fluid space. Lerma and colleagues made a diffusion mathematical model for this 
system. The assumptions of their model were that simple diffusion guided biomolecules across the 
membrane, concentration was constant around the probe, and steady-state conditions.58 Equation 1.7 
summarizes their method.  The concentration of perfusate is represented by c, A represents extracellular 





At t = 0 or beginning of perfusion, the concentration of the perfusate (c) is zero, but after sufficiently long 
times (t → ∞) the concentration of the perfusate will be equal to the concentration of biomolecules in the 
extracellular fluid. In other words, the perfusate and extracellular fluid will be at equilibrium allowing to 
determine the concentration of the extracellular fluid for any biomolecule. 




Figure 1.12. Lerma et al.’s microdialysis sampling circulation experimental set up.58 Reprinted from 
reference 58, Copyright 2017, with permission from Elsevier. 
 
Sternberg et al. eight years later, in 1994, developed a calibration method for glucose sensors 
using a microdialysis sampling recirculation device to determine subcutaneous concentrations of glucose 




Their method consisted on recirculating a perfusion fluid (phosphate saline), using a peristaltic pump, inside 
a microdialysis probe until a concentration equilibrium was reached between the glucose concentration 
outside the microdialysis probe membrane and the inside. Similar to Lerma et al.’s work, they increased 
the residence time of the perfusion fluid. This in terms helped them determine the glucose concentration 
present in the tissue. Sternberg et al. listed five reasons why their recirculation method was very effective, 
see Table 1.4.59 One of the reasons was that a small amount of liquid is continuously in contact with the 
extracellular fluid preventing any adverse responses from the sampling site.59  
Table 1.4. Sternberg et al. reasons why their calibration method is effective.59 
a) Microdialysis probe implantation does not interfere with results within 30 minutes 
after implantation 
b) Only a small amount of volume is in contact with the extracellular fluid continuously 
minimizing any adverse reaction 
c) The dialysate is constantly stirred 
d) Surface area and residence time allow for a total equilibrium to occur 
e) Blood contamination is avoided by using a semipermeable membrane 
 
In 1995, Sternberg at al. published the same paper or similar than their 1994 recirculation paper, 
but this time they called their method “the recirculator”.60 In this work they estimated subcutaneous glucose 
concentration in humans and continuously monitored the concentration changes using a recycling system.60 
They found that fifteen cycles were needed to achieve equilibrium between recirculated phosphate buffer 
saline inside microdialysis probe and plasma glucose or standard solution of glucose outside of it.  
One interesting observation about Lerma et al. work and Sternberg et al’s is that as far as this 
author knows since 1995 no other work further investigating or improving this method have been published. 
Their recirculation method seems to be a very effective way to eliminate microdialysis sampling calibration 
methods. The preliminary work for this dissertation consisted of a similar method of recirculation or recycling 
microdialysis sampling to improve relative recovery and eliminate microdialysis sampling calibration 




 Transmembrane pressure 
Microdialysis sampling is not only driven by diffusion, but also by hydraulic pressure. According to 
Bungay et al.,”It is customarily assumed that no significant amount of the perfusate fluid is loss across the 
probe membrane and that solute exchange across the membrane occurs by diffusion.”61 This assumption 
causes errors during the interpretation of experiments conducted using microdialysis sampling probes of 
high molecular weight cutoff (e.g., 100 kDa) membranes. However, understanding how pressure influences 
the relative recovery of biomolecules during microdialysis sampling experiments can be very useful.  
Bungay et al. demonstrated how relative recovery of biomolecules can be improved by changing 
the transmembrane pressure of microdialysis sampling probes, see Figure 1.14.  Their experiment 
consisted on changing the height of the collection vial or the outlet tubing of a microdialysis sampling probe 
to change the transmembrane pressure. To explain, when the vial is elevated an increase in backpressure 
or hydraulic resistance is generated inside the microdialysis probe. This causes an increase in fluid loss 
across the membrane. On the other hand, when the vial is lowered a positive pressure is generated inside 






















This gain or loss was defined by Bungay and colleagues as an ultrafiltration factor, see Equation 8. In this 
equation, Qin and Qout represent the flow rate of the perfusion fluid and the dialysate respectively. For fluid 




                                          Equation 1.8 
Recently, Chu et al. found a direct relationship between fluid recovery (FR), and static pressure.62, 
63 They studied the importance of transmembrane pressure in fluid recovery by using a pressured chamber 
that they designed, see Figure 1.15.64 Their work consisted on changing the pressure outside and inside 
the microdialysis probes systematically. They used four CMA 71 microdialysis sampling probes for their 
experiments having membranes of 100 kDa MWCO and 10 mm in length. These probes were placed inside 
a chamber and each probes were connected to syringe pumps.62 It is good to point out that these probes 
were not connected in series. The chamber allowed them to control the pressure outside the microdialysis 
probes. It is a common practice to add osmotic agents during microdialysis sampling experiments that use 
microdialysis probes having membranes of 100 kDa or larger MWCO. These agents such as dextrans 
counterbalance the pressure inside the probe. This approach helps reduce fluid loss during microdialysis 









Figure 1.14. Transmembrane pressure experimental set up to improve microdialysis sampling recovery.61 















Figure 1.15. Pressure chamber engineered to study transmembrane pressure influence on recovery.63, 64 
(From reference 64, open access article, with permission to reuse under the terms of the Creative Commons 
License, see appendices for details) 
 
The experiments described by Chu et al. were the first to study the influence of osmotic, 
transmembrane, hydraulic, and outside probe or sampling site pressure on fluid recovery during 
microdialysis.62 Their work could lead to an automated microdialysis sampling system in which pressure 
sensors control the pressure in the system. For example, during in vivo experiments the pressure outside 
microdialysis probes changes depending on the sampling site internal pressure. This impacts the 
transmembrane pressure of the probes and the relative recovery. This will be addressed on chapters 3 and 
4. By assuming that the pressure applied to the microdialysis sampling probe or hydraulic pressure (flow 




In other words, the pressure change would be the difference between the hydraulic pressure and the 
pressure outside the microdialysis sampling probe. Regulating this pressure change systematically could 
lead to higher relative recoveries.       
 Microdialysis probes in series 
Microdialysis probes in series is a new approach that was developed during this dissertation to 
improve the relative recovery of biomolecules during microdialysis sampling and toward eliminating the 
need for microdialysis sampling calibration methods. Microdialysis probes in series approach optimizes 
membrane surface area and perfusion fluid residence time to increase relative recovery of macromolecules. 
As far as the author know nobody has done something similar. The new approach consisted of up to four  
microdialysis probes in series, see Figure 1.16. 
Figure 1.16. Four microdialysis probes in series system. 
 
As far as this author knows there are not similar work published in the scientific literature. However, 
there is a patent65 similar to the work of this dissertation. The aims of this dissertation and the patent were 
different, since four microdialysis probes were not going to be implanted in any living system. It is good to 
point out that this dissertation work was used to assess the difference between theory and experiment. 
Previously researchers have implanted four microdialysis probes in living systems in order to assay a larger 
sampling area and closely monitor concentration changes of biomolecules. This is done to have a higher 




For example, Wei et al. implanted four microdialysis probes in the heart of dogs to study the enzymatic 
mechanism of angiotensin II in the interstitial fluid. Another example was the work done by Strouch et al. 
They implanted four CMA/20 microdialysis probes subcutaneously in swine to study the extracellular cyclic 
adenosine monophosphate.66 It is good to point out that these microdialysis probes in both of those studies 
were not connected in series or parallel. Samples were taken from them independently. Wei’s and Strouch’s 
groups wanted to map the concentration of their analyte by using multiple microdialysis probes. The 
problem of implanting multiple microdialysis probes in any living system is the amount of damage that it 
causes to the tissue from which samples are been taken. Nevertheless, if the concentration changes of a 
biomolecule want to be studied in any organ, more than one microdialysis probe could be used to cover a 
larger area. Finally, Lu and colleagues glued four probes together to be implanted and used to sample 
biomolecules, see Figure 1.17. Their work showed that microdialysis probes could be arrayed in series and 
parallel.65 The four microdialysis probes in series approach was used as the basis to develop a 
polydimethylsiloxane (PDMS) microfluidic-based microdialysis probe. 
 Microfluidic devices used or applied to microdialysis sampling  
Manufacture of microfluidic devices is emerging as one the fastest growing research areas.67 It is 
estimated that this year (2016), pharmaceutical & biomedical research will use $1 billion worth of 
microfluidic devices. The microfluidics market is expected to reach $4 billion this year.68 The combination 
of microfluidic devices and microdialysis sampling in order to develop a diagnostic system able to monitor 
in real-time concentration changes of biomolecules and make faster diagnosis, unlike traditional methods, 
during disease states is needed. Researchers have developed different approaches to tackle this need. 
Finally, the number of publications related to microfluidics and membranes have had a substantial growth 



























Figure 1.18. Growth in the number of publications related to microfluidic and membranes.69 Reproduced 




1.6.1 Microfluidic devices based on microdialysis sampling 
 Miniaturization 
There is a growing interest in miniaturizing microdialysis sampling technique into microfluidic 
systems.70, 71, 72 The advantages of achieving this are: a) Significant reduction in cost, b) smaller sample 
volume, and c) faster results. On other hand, according to Tüdős et al., “The large ratio of volume and flow 
rate between the microfluidic components and their associated conventional fluidics raises considerable 
system integration challenges when miniaturised devices are incorporated into instrumentation.”70 That is 
while the growing interest in miniaturizing microdialysis sampling into microfluidic systems and microfluidics 
in general, has created a need for engineering fundamental work.70 Some of the engineering tools used to 
develop microfluidics are summarized in Table 1.5.70 One of these tools is dialysis, used to separate 
biomolecules as previously mentioned in this chapter. 
Since microdialysis sampling technique requires a membrane to allow the separation of analytes 
from complex matrices, choosing the appropriate fabrication approach is crucial for a successful microfluidic 
device. An in-depth review about membranes and microfluidics has been provided by de Jong et al.69  
They divided several fabrication approaches used to integrate membranes in microfluidic systems into four 
categories, see Table 1.6.69 1) Direct incorporation of (commercial) membranes, 2) membrane preparation 
as part of the chip fabrication process, 3) in-situ preparation of membranes, and 4) use of membrane 
properties of bulk chip material were the four categories developed by de Jong and colleagues.69  
Table 1.5. Summary of engineering tools used for microfluidics.70 Reproduced from reference 70 with 









Table 1.6 shows more details about their categories. For the work done for this dissertation, the category 
one was used. To explain, commercially available polyethersulfone (PES) membranes were used to make 
the devices. PES was the membrane material of choice, since microdialysis probes having PES 
membranes were used. Chapter 5 is going to cover this in more detail. Finally, de Jong et al made a useful 
flow chart to help researchers choose membranes and fabrication approaches suitable for their needs, see 
Figure 1.19.69  
 Microfluidic microdialysis devices 
Several researchers have designed and developed microdialysis devices to sample or monitor 
biomolecules. For instance, Hsieh and Zahn devised a microfluidic microdialysis biochip for glucose 
recovery.71 They engineered an in vitro on-chip microdialysis system to study concentration changes of 
glucose. The key feature of their design was that for the microdialysis probe membrane they used thin-film 
fabrication technique and direct polymer bonding giving them a more efficient microdialysis system. This 
was due to the fact that high surface to volume ratio can be achieved with these techniques.71  
Subrebost  developed a similar microfluidic system for his PhD dissertation.73 Subrebost’s system 
consisted of a membrane at the tip of an a silicon chip. His device has an on-chip fraction collector and 
embedded platinum planar electrodes used as a membrane biofouling control.73  However, Subrebost 
system was designed, but never tested experimentally. 
Recently, Lee et al. published a work showing a new method to microfabricate microdialysis probes 
in silicon.74 They were able to fabricate a microdialysis probe 79% smaller (160 µm) than the smallest 
conventional microdialysis probes’ cross-sectional area, see Figure 1.20.74 Lee and colleagues used a flow 
rate of 100 nL/min (0.1 µL/min).74 As previously stated in this chapter and they stated in their conclusions, 
such as small flow rates are a drawback.  
The main difference between Subrebost’s design and this dissertation’s design was that 
Subrebost’s design focused on membrane biofouling. The design outlined in this dissertation was focused 
on miniaturizing the microdialysis probes in series approach. An approach developed to eliminate the need 




Table 1.6. Division of fabrication approaches by de Jong et al’s.69 Reproduced from reference 69 with 


























Figure 1.19. Flow chart for membrane and fabrication selection made by de Jong et al.69 Reproduced from 

















Figure 1.20. Lee at al. small microdialysis probe.74 Reprinted with permission from reference 74. Copyright 
2017 American Chemical Society. 
 
Hsieh and Zahn mentioned above, developed another device in 2007 to monitor glucose on a 
polydimethylsiloxane (PDMS) microfluidic system.71 Their microdialysis on-a-chip system used platinum 
electrodes to measure the glucose concentration and a micromixer to avoid concentration gradients due to 
not well-mixed flows. Microdialysis type microfluidic systems have also been used for protein 
preconcentration. Kim et al. devised a microfluidic dialysis system to enrich protein samples by modifying 
the dialysis membrane with oxygen plasma.75They modified the dialysis membrane using oxygen plasma 
treatment to change the hydrophobicity of the membrane surface to improve flux and selectivity. They made 
serpentine channels on two PDMS substrates. These two PDMS substrates were used to sandwich a 




The microfluidic system that was developed for this dissertation could be another step toward 
eliminating the need for microdialysis sampling calibration methods, due to the fact that the microdialysis 
probes in series approach was able to achieve ~100 % recovery of small molecules such as methyl orange 
in in vitro experiments. This means that the concentration of analyte collected would be approximately the 
same as the concentration in the sampling site, ideally, and microdialysis sampling calibration methods 
would not be necessary. Eliminating microdialysis sampling calibration methods, would be one of the 
greatest achievement of the field, if reached.  
The PDMS microfluidic device was developed by miniaturizing the microdialysis probes in series 
method, see Figure 1.16. An external pump and analytical benchtop detection methods still need to be used. 
The main aim was to make a microdialysis probe-like device better, in terms of recovery, than the current 
commercially available. The idea was to mimic the four microdialysis probes in series approach by having 
four channels connected in series, but parallel to each other, see Figure 1.21. The number of probes required 
to achieve ~100% relative recovery of methyl orange was determined in vitro. A mathematical model based 
on Bungay’s and Jacobson’s work was devised to estimate the number of microdialysis probes in series 
necessary to achieve ~100% recovery of methyl orange and isothiocyanate-dextrans (FITCs), see Equation 
1.6. By translating the number of probes necessary to achieve ~100% recovery of any analyte into number 
of channels, the microfluidic device could be tailored for wide range of biomolecules based on their mass 
transfer coefficient (k), see Equation 1.6. From a practical standpoint, this would be more like a calibration 
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2 Chapter 2. Proof of principle recycling flow approach using 100 µM methyl orange solution 
 Background and Significance 
This chapter describes the work that was performed to demonstrate that a recycling flow approach 
could be used to improve relative recovery of small molecules during microdialysis sampling experiments. 
Methyl orange, a small molecule of 330 Da was used as the analyte. A solution of 100 µM methyl orange 
in high performance liquid chromatography (HPLC) grade water was used. The availability and cost of 
methyl orange made it an ideal analyte for this work. The recycling flow experiments described in this 
chapter laid the foundation of the microdialysis probes in series approach. A detailed description of the 
microdialysis probes in series approach is covered in chapter 3. Experiments were conducted to evaluate 
the number of microdialysis probes in series necessary to achieve ~100% relative recovery. The 
experiments were performed under quiescent and stirred conditions. The main purpose was to study the 
influence of flow rate and number of cycles on relative recovery.  
 Experimental section 
A solution of 100 µM methyl orange (Sigma-Aldrich, St. Louis, MO) in HPLC grade water was used 
as the target analyte. A 0.6 mL plastic reservoir was used to place the microdialysis probe. The microdialysis 
probe used was a CMA/20 microdialysis probe having a 10-mm polyethersulfone (PES) membrane of 100 
kDa molecular weight cutoff (MWO) (Harvard Apparatus, Holliston, MA), see Figure 2.1. A MAB-20 
microdialysis pump was used to recycle the dialysate through the probe (Microbiotech, Stockholm, 
Sweden), see Figure 2.2. HPLC grade water was used as perfusion fluid. One cycle was defined as one 
dialysate or sample collection. This was equivalent to collections conducted during regular microdialysis 
sampling. The first dialysate collected was used as perfusion fluid for the second collection, the second 
dialysate collected was used as perfusion fluid for the third collection, and so on, see Figure 2.3. The 
experiments were performed under quiescent and stirred conditions see Figure 2.2 and Figure 2.4. The 
bulk of the experiments were performed under quiescent conditions. The flow rates used for the recycling 
flow microdialysis experiments under quiescent condition were 0.8, 1.0, 2.5, and 5.0 µL/min. A flow rate of 
2.5 µL/min was used for the recycling experiments performed under stirred (on a stir plate at 800 rpm) 

















Figure 2.2. Recycle flow set up used for microdialysis experiments conducted under quiescent condition 




Figure 2.3. Set up used to recycling flow experiments. Point a) HPLC grade water reservoir (perfusate). 























Figure 2.5. Comparison of relative recovery (RR) of 100 µM methyl orange under quiescent and stirred 
conditions during microdialysis recycling flow experiments using a 100 kDa CMA/20 microdialysis probe 
having a 10 mm PES membrane in length, 5 cycles. HPLC water was used as perfusion fluid at 2.5 µL/min. 
n = 3, *n = 2, and average ± standard deviation  
 
The maximum number of cycles used for the collections of methyl orange under quiescent condition was 
four for 0.8, 1.0, and 5.0 µL/min, and five and ten cycles for 2.5 µL/min, see Figure 2.5, Figure 2.6, and 
Figure 2.7. The absorbance of each dialysate was measured at a wavelength of 466 nm using a 
TecanSpectraFluor plate (96 wells) reader (Tecan Group Ltd., Männedorf, Switzerland) and was compared 
vs. a calibration curve. At least 50 µL of dialysate was required for measurement with the plate reader. 
Three aliquots were taken from each dialysate and each one was diluted to 100 µL in HPLC grade water. 
 Results and discussion  
A logarithmic relationship between flow rate and the number of cycles was found for the recycling 
flow experiments, see Figure 2.6 and Figure 2.7. This finding is in line with what has been previously 
reported in the literature by Lerma et al.1 The highest relative recoveries for methyl orange using recycling 
flow were obtained at 0.8 µL/min and 4 cycles (100.3%) and 2.5 µL/min and 9 cycles (98.1% ± 2.7%), see 





























Figure 2.6. Relative recovery (RR) of 100 µM methyl orange under quiescent conditions collected during 
microdialysis recycling flow experiments at 2.5 µL/min, 10 cycles. HPLC water was used as perfusion fluid. 












Figure 2.7. Relative recovery (RR) of 100 µM methyl orange using recycling flow method under quiescent 





This was expected for a diffusion-based technique such as microdialysis. The residence time or the time 
analyte stays in contact with the perfusion fluid across the membrane/sample interface, increases at lower 
flow rates. Lower flow rates allow more time for methyl orange to diffuse through the microdialysis 
membrane and be carried by the perfusion fluid. Therefore, fewer cycles are needed as compared to higher 
flow rates. Higher flow rates require more cycles to increase the residence time. For the experiments 
conducted under stirred condition the relative recovery of methyl orange as a function of the flow rate was 
higher (83.9% ± 0.6%) compared to the quiescent experiments (68.5% ± 4.9%), see Figure 2.5. This is due 
to the fact that the mass transport resistance of the quiescent medium external to the microdialysis probe 
(Rq) approaches zero in well-stirred solutions reducing its influence on the relative recovery (see Equation 
1.2 in chapter 1). The problem with collecting 50 µL was that it significantly increased the amount of time 
necessary to conduct an experiment due to the experimental set up chosen. As can be seen on Table 2.1 
~8 hours and 20 minutes were needed to conduct one set of experiments for one flow rate. This was 
necessary to conduct the five-cycle’s experiments. The rinse time was determined by measuring the time 
that the perfusion fluid took from the reservoir to the collection vial (from point “a” to point “c”), see Figure 
2.3. The set up was chosen in order to have more control over each individual cycle. To reduce time, sample 
volume, and cost, a different approach was developed. The flow rates used for the microdialysis in series 
approach experiments, chapter 3, were based on the results obtained on this chapter. The new approach 
consisted of several microdialysis probes in series. 
 






Notes: The calculated collection volume was calculated by multiplying the flow rate times the collection 
time.   
Cycle # Calculated collection volume (µL) Collection time (min) 
1 450 180 
2 350 140 
3 250 100 
4 150 60 
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3 Chapter 3. In vitro collection of methyl orange and fluorescein isothiocyanate-dextrans (FITCs) 
using microdialysis probes in series 
  Introduction  
A new microdialysis sampling method was developed to reduce the amount of time, sample 
volume, and cost required to perform the recycling flow experiments (Table 2.1). The new approach 
consisted of two microdialysis probes in series, see Figure 3.1 and Figure 3.2. The number of microdialysis 
probes connected in series was extended to four probes, see Figure 3.3. Four microdialysis probes was 
the maximum number probes in series that was tested for this work. The method was called microdialysis 
probes in series due to the fact that microdialysis sampling probes were connected in series. To evaluate 
the probes in series method two set ups were used. The reservoir where the microdialysis probes in series 
were placed went through different iterations. This was done to minimize the volume of analyte needed for 
the experiments. In this chapter, the was to demonstrate in vitro microdialysis probes in series approach 
for a series of compounds with a wide-range of molecular weight (methyl orange, FITC-4, FITC-10, FITC-
20, and FITC-40). This work serves as a proof of principle for next generation microdialysis probe. The 












Figure 3.1. Microdialysis probes in series method having each probe in separate vials (two probes), 0.6 

















Figure 3.2. Microdialysis probes in series method having the probes in the same vial (two probes), 20.0 















  Experimental section 
3.2.1 Proof of principle and initial settings 
The microdialysis probes in series approach went through a series of iterations as mentioned 
before, see Table 3.1. This was done to reach the optimal settings of the method for future experiments 
using proteins. The first set of iterations consisted of two and four microdialysis probes in series, see Figure 
3.1, Figure 3.2, and Figure 3.3. These probes were either placed in separate reservoirs or in the same 
reservoir. A CMA 110 liquid switch from Harvard Apparatus, Holliston, MA was used as tubing holder to 
facilitate the connections between probes, see Figure 3.4. The MAB-20 pump previously used for the 
recycling flow experiments, chapter 2, was replaced by a BASi syringe pump system (West Lafayette, IN). 
Microdialysis probes (CMA/20) of 100 kDa molecular weight cutoff (MWCO) and 10 mm polyethersulfone 
(PES) membrane were from Harvard Apparatus (Holliston, MA). The absorbance of each dialysate was 
measured at a wavelength of 466 nm using a TecanSpectraFluor plate (96 wells) reader (Tecan Group 
Ltd., Männedorf, Switzerland) to determine their concentration using an appropriate calibration curve.  
 








Two probes in 
separate vials.  








volume of ≥ 50 µL. 
Samples were 
diluted. 
0.6 mL vials for probes 
placed separate and 20.0 mL 
house-made container for 
probes placed together using 
Parafilm M® and a plastic lid. 
2 Same Same 
NanoDrop 2000 
requiring sample 
volume of 2 µL. 





or 0.1% BSA in 
10 mM PBS pH 
7.4 
Same 
0.6 mL vials for probes 
placed separate and 5.0 mL 
house-made plastic vial for 
probes place together. 
4 Same 
4% dextran-70 
in 10 mM PBS 
pH 7.4 
Same 
0.6 mL vials for probes 
placed separate and ~2.5 mL 
house-made plastic vial 
wrapped with aluminum foil 













Figure 3.4. Four microdialysis probes in series in the house-made ~2.5 mL reservoir showing aluminum 
paper for light protection. 
 
At least 50 µL of dialysate was required in order to measure the concentration of methyl orange samples 
using the plate reader. Three aliquots were taken from each dialysate and each one dilute to 100 µL in 
HPLC grade water.  
For this set of iterations, a solution of 100 µM methyl orange in HPLC grade water was used as the analyte. 
A house-made reservoir was built to hold the microdialysis probes in the same container. The reservoir was 
made out of a plastic lid and Parafilm M®, see Figure 3.2 and Figure 3.3. The volume of the reservoir was 
20.0 mL. The reservoirs used for the microdialysis probes placed in separate reservoirs were clear plastic 
microvials of 0.6 mL. Collections of two independent microdialysis sampling experiments, regular 
microdialysis, were added. This was done to compare the relative recovery of two probes in series in 
separate and same reservoir versus adding the relative recoveries of two probes from separate 
microdialysis experiments. The flow rate used for these experiments was 2.5 µL/min. For the next iteration 
a NanoDrop 2000 UV-Vis spectrophotometer from Thermo Scientific (Wilmington, DE) was used to 
measure the absorbance of the dialysates. The advantage of using the NanoDrop is that it only requires 2 
µL of sample volume, reducing significantly the sample size and collection time. From this point forward, all 




For these experiments 100 µM methyl orange solution was used as the analyte and HPLC water as the 
perfusion fluid. The flow rates used were 1.0, 1.5, 2.0, 2.5, 3.0, and 4.0 µL/min. The 20.0 mL plastic reservoir 
was used.  
After several experiments performed using HPLC water as the perfusion fluid, the chemical 
composition of the perfusion was changed to match the composition of the extracellular fluid. The chemical 
or ionic composition of the extracellular fluid is: Sodium 0.142 mol, potassium 0.005 mol, calcium 0.002 
mol, magnesium 0.001mol, chloride 0.105 mol, bicarbonate 0.024 mol, and phosphate 0.0007 mol.1, 2 This 
is commonly used to maintain appropriate osmotic pressure and ionic composition. Also, it is used to 
minimize the level of disturbance of biology in living systems during microdialysis sampling collections 
performed in vivo. The perfusion fluid used for the in vitro experiments was a solution of 10 mM phosphate 
buffered saline (PBS) pH = 7.4 having either 4% (w/v) dextran-70 or 0.1% (w/v) bovine serum albumin 
(BSA) from Sigma-Aldrich, St. Louis, MO. It is good to point out that for this dissertation in vivo experiments 
were not conducted. The PBS used for this dissertation was composed of 10 mM disodium phosphate, 1.8 
mM monopotassium phosphate, 2.7 mM potassium chloride, and 137 mM sodium chloride. Calcium 
chloride dihydrate and magnesium chloride hexahydrate are supplemented in some applications such as 
in vivo experiments.3 The objective of adding dextran-70 and BSA was to evaluate how these osmotic 
agents would influence the relative recovery of methyl orange.4, 5  
The flow rates used were 1.0, 2.5, and 5.0 µL/min. HPLC water was used as control. Previously, Parafilm 
M® was used to hold the microdialysis probes connected in series for the 20.0 mL plastic reservoir. The 
problem with using this is that it is very fragile and tends to give away. A new 5 mL reservoir able to hold 
four microdialysis probes firmly was made for these experiments. One of the aims of this iteration was made 
to reduce the volume of the reservoir from 20.0 mL to 5.0 mL. 
The last iteration was made to the microdialysis in probes in series approach. This was done to 
further reduce the volume of the reservoir from 5 mL to ~2.5 mL. Aluminum foil was used to minimize the 
interaction of light and the analyte in the reservoir of ~2.5 mL, see Figure 3.4. All experiments done using 
this reservoir used aluminum foil unless otherwise stated. By reducing the volume of analyte in the reservoir, 




The idea was to eventually use the method to collect proteins such as cytokines. It is good to point out that 
proteins were not used for this dissertation. 
3.2.2 Four microdialysis probes in series 
For this last iteration, four microdialysis probes in series, a set of experiments were conducted. 
Solutions of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 were prepared in 10 mM 
phosphate buffered saline (PBS) pH = 7.4. The perfusion fluid used for the experiments was 10 mM (PBS) 
pH = 7.4 having 4% dextran-70 as osmotic agent commonly used in microdialysis experiments to reduce 
fluid loss and “counterbalance the transmembrane hydrostatic driving pressure”.4 All the chemicals used 
were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. BASi syringe pumps and 
gastight 1.0 mL syringes were used (Bioanalytical Systems Inc., West Lafayette, IN). Microdialysis probes 
(CMA/20) of 100 kDa molecular weight cutoff (MWCO) and 10 mm polyethersulfone (PES) membrane were 
used. The idea behind these experiments was to obtain detailed information about the relationship between 
recovery, number of probes in series (i.e., 1, 2, 3, and 4), flow rate, and molecular weight. Probes were 
connected to each other in series without altering the standard tubing lines (200 mm length and 0.12 mm 
internal diameter inlet and outlet lines) that comes with the CMA/20 dialysis probes. For the number of 
probes in series the collection through one or a single microdialysis probe was used a control. This was 
chosen because one microdialysis probe is commonly used during microdialysis sampling experiments. 




The same experiments were conducted having two, three, and four microdialysis probes in series. Figure 
3.5 shows a schematic representation of the new four microdialysis probes in series approach. Flow rates 
of 0.8, 1.0, and 1.5 µL/min were used.  
A simple and straightforward procedure was developed: a) Perfuse perfusion fluid (PBS) for ~15 
min or until dialysate absorbance was within 5% relative standard deviation (RSD), measurements were 
performed in triplicate unless otherwise stated, b) measure the absorbance of the outside solutions or 
solutions place in the in-house made plastic container before changing to a new flow rate, and c) after 
changing flow rates flush the system for the same amount of time and criteria than “a” to avoid cross 
contamination from one flow rate to another. 
 Results and discussion 
3.3.1 Proof of principle and initial settings 
Figure 3.6 shows the relative recoveries of 100 µM methyl orange collected using two microdialysis 
probes either in series or individually. According to these preliminary results the relative recovery of methyl 
orange was higher (46.0% ± 1.7%, n=3) when microdialysis probes were connected in series and placed 
in the same reservoir than when they were placed in separate reservoirs (36.1%, n=2). This could be due 
to fluid loss having a greater impact or diluting the methyl orange in a smaller reservoir (0.6 mL) than in the 
larger reservoir (20.0 mL) used to place the two probes together.  
As comparison, relative recovery of methyl orange was determined using two microdialysis probes. 
To explain, the relative recoveries were added together, and the total was used to compare it to the two 
probes in series. These two microdialysis probes were not connected in series, but regular microdialysis 
sampling experiments were performed on both. The relative recoveries of these microdialysis probes were 
26.0% ± 1.3%, n=3 and 22.2% ± 1.1%, n=3 respectively. The total relative recovery of these probes was 
48.2% ± 1.7%, n=3. The fluid loss and transmembrane pressure of two probes in series is significantly 
different than having two separate microdialysis probes. Fluid loss will be address in more detail later in the 
chapter. When four microdialysis probes were connected in series a relative recovery of 100.8% ± 2.4%, 




The outside solution was under quiescent condition and HPLC water was used as perfusion fluid without 
any osmotic agents. Compared to the recycling flow method relative recoveries obtained under similar 
conditions, the four microdialysis probes in series relative recoveries were higher, see Figure 3.7. For 
example, the methyl orange relative recovery using four probes in series at a perfusion rate of 2.5 µL/min 
was 83.9% ± 1.3%, n=3 and the methyl orange relative recovery using recycling flow (four cycles) at the 
same rate was 75.0% ± 0.3%, n=3. These results are a good indication of the benefits of adding 
microdialysis sampling probes in series for small molecules. Nevertheless, the opposite effect was found 
for large molecules such as FITC-40. For larger molecules the fluid loss is the critical factor influencing 
relative recovery. This will be addressed in the four probes in series discussion, section 3.3.2.  
Several perfusion fluids of different chemical compositions were tested using a reservoir of 5 mL to 
hold the microdialysis probes in series more firmly. The results are shown on Figure 3.8. The perfusion fluid 
that yielded the highest relative recovery of methyl orange was 4% dextran-70 in 10 mM PBS. For instance, 
the relative recovery of methyl orange using this perfusion fluid at 2.5 µL/min was 94.0% versus the control, 
HPLC water, 80.1%. These results are in agreement with what is found in the literature on regular 
microdialysis sampling, even though the transmembrane pressure in the microdialysis in series approach 









Figure 3.6. Relative recovery (RR) of 100 µM methyl orange in HPLC water using two microdialysis probes 
in series in the 20.0 mL reservoir under different settings at 2.5 µL/min. (Control = Avg. Pr-1 & Pr-2). n = 3, 
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Figure 3.7. Comparison of relative recovery (RR) of 100 µM methyl orange using microdialysis recycling 
flow and four probes in series method at different flow rates. Four cycles and four probes in series were 





According to Li et al., “To minimize fluid loss from the probe due to osmotic effect, the osmolarity 
of the perfusate is often adjusted to balance the physiological osmolarity by adding osmotic agents, e.g. 
dextran-70 or a protein such as bovine serum albumin (BSA).”6 Regulating the transmembrane pressure or 
fluid loss across microdialysis probe membranes is vitally important during microdialysis sampling 
experiments, especially during in vivo experiments. 
3.3.2 Four microdialysis probes in series 
Figures 3.9, 3.10, and 3.11 show the relative recoveries of FITCs and methyl orange collected 
using one, two, three, and four probes at different flow rates (0.8, 1.0, and 1.5 µL/min), respectively. These 
results show that the relative recovery significantly improves as the number of probes in series increases. 
For instance, if the collections of methyl orange at 0.8 µL/min for one probe or control (regular microdialysis) 
(66.7 ± 4.6 %, n=3) and four probes (99.7 ± 1.0 %, n=3) are compared, you can see the significant 
improvement on the recovery (~33%). However, when we compared the recoveries of two probes versus 













Figure 3.8. Relative recovery (RR) of 100 µM methyl orange under different perfusion fluid chemical 
compositions and flow rates using 5.0 mL reservoir and four probes in series method. 
 
 
This could be explained by the size and diffusion properties of methyl orange (330 Da, and a high mass 
transfer coefficient, kA, of ~0.9 µL/min). For one probe the surface area of the system is at its minimum, 
but the concentration gradient is higher. As the number of probes increases the surface area becomes 
larger (greater residence time) increasing recovery, but decreasing concentration gradient. Since the 
probes are in series, the dialysate of one probe becomes the perfusate of the probe attached to it. As a 
result, the concentration gradient decreases due to the presence of a non-zero analyte concentration inside 
the probe (membrane) relative to the outside. That is why after two probes in series there is a steady 
increase in recovery rather than a sharp one. Another factor that could play a role in this behavior is osmotic 
pressure or fluid loss. For example, the fluid losses measured during microdialysis probes in series 
approach experiments using 100 µM methyl orange as the analyte were as follows: 1) One probe or control 
+8.40% (gained fluid), 2) two probes in series -1.30%, 3) three probes in series -11.40%, and 4) four probes 
in series -28.40%. The fluid losses were quantified by measuring the amount of dialysate collected over a 
set period of time and relating this to the pumping flow rate. For instance, collections conducted at a 
pumping flow rate of 5.0 µL/min for 2 min would yield a dialysate volume of 10.0 µL, if not fluid loss or gain 




Thus, if fluid loss was present and the dialysate measured volume was 7.0 µL, it would yield a fluid loss of 
-30% for FITC-4, see Figure 3.9, the change in recovery from one probe to four probes at 0.8 µL/min was 
~32% (34.1% vs. 66.3%) and after two probes in series the difference was ~11%.  
Overall the change in relative recovery from one probe to four probes was follows: a) Methyl orange 
~33%, b) FITC-4 ~32%, c) FITC-10 ~17%, d) FITC-20 ~4%, and e) FITC-40 ~2%. It is good to point out 
that even though the change in recovery for methyl orange and FITC-4 were similar, their relative recoveries 
were different for one probe and four probes. These results show how molecular weight not only affects 
recovery, but also the diffusion behavior of molecules across a membrane. For larger molecules the 
increase in relative recovery as the surface area increases is linear as compared to smaller molecules 
logarithmic, see Figures 3.9, 3.10, and 3.11. This is because as the concentration of molecules increase 
(for a fixed period of time), for larger molecules, inside the microdialysis probe membrane, the movement 
of them decreases. In other words, there are more molecules colliding into each other to move from outside 

























Figure 3.9. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 at 
0.8 µL/min flow rate using probes in series. One probe on the above graph represents the control or regular 
microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes a one-
way ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n = 3 and 






   
Figure 3.10. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 
at 1.0 µL/min flow rate using probes in series. One probe on the above graph represents the control or 
regular microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes 
a one-way ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n = 
























Figure 3.11. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 
at 1.5 µL/min flow rate using several probes in series. One probe on the above graph represents the control 
or regular microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes 
a one-way ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n = 




Another factor that could be playing a role on how the relative recovery of larger molecules 
increases as a function of adding microdialysis sampling probes in series (increasing surface area) is the 
mass transfer coefficient (k). Mass transfer coefficient is a rate constant for molecules moving from the 
boundary to the bulk per area.8This is commonly used in engineering to analyze diffusion processes. When 
k is large, a faster mass transfer is taking place. On the other hand, when k is small the mass transfer is 
slower.8 There is an inverse exponential relationship between molecular weight and k for the CMA/20 
microdialysis probe used, see Figure 3.12. These values were determined experimentally in order to 
estimate how many probes were needed to achieve nearly 100% recovery using this system. The latter will 
be addressed in detail in chapter 4. To sum up, increasing the number of probes in series (up to 4 for methyl 
orange) or surface area significantly improves relative recovery and it is limited by the pore size or MWCO 
of the microdialysis probe. 
To determine if a greatly reduced convective force would increase the relative recovery for 
increased probes, we set up a recycled microdialysis sampling system with a peristaltic pump. As previously 
mentioned in section 3.3.1, for small molecules (330 Da) such as methyl orange the relative recovery during 
microdialysis probes in series experiments were higher than recycling flow method, see Figure 3.7. 
However, the opposite was true for large molecules (FITC-40, 40 kDa), see Figure 3.13. This could be due 
to the mass transfer differences between methyl orange (kA~0.9 µL/min) and FITC-40 (k~0.05 µL/min). 
The relative recovery of FITC-40 using the recycling flow method for four cycles was almost two times 
higher than the relative recovery of FITC-40 during four probes in series experiments. During recycling flow 
experiments the fluid loss is minimal, since the same fluid is recirculated in one microdialysis probes. Methyl 
orange is approximately eighteen times faster than FITC-40. This allows methyl orange to overcome the 















Figure 3.12. Relationship between molecular weight (MW) and mass transfer coefficient (kA) for a CMA/20 














Figure 3.13. Comparison of the relative recovery (RR) of 100 µM FITC-40 using the recycling flow and the 
probes in series method at 1.0 µl/min. The perfusion fluid was 4% dextran-70 in 10 mM PBS pH = 7.4. n = 
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 Conclusion  
 An in vitro method consisting of four microdialysis probes in series to determine the needed number 
of probes for the collected dialysate to reach near equilibrium with the solute concentration was devised. 
This method significantly improved the recovery of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 
without the need of using slow flow rates (< 0.5 µL/min). This work may serve as a basis for the development 
of a programmable microfluidic system for the collection of biomolecules.   
 Additionally, one could envision using this approach to get an estimate of in vivo concentrations 
and use it periodically within experimental runs to verify in vivo concentrations. To continuously run with 
multiple probes will certainly reduce temporal resolution, but again it could be used at the start and 
completion of an in vivo experiment to gain important information about biological concentrations, without 
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4 Chapter 4. Recovery estimations of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 
using a modified version of Jacobson et al. linear regression method and Bungay’s 
mathematical model for microdialysis sampling 
 Introduction  
 After demonstrating that the microdialysis sampling probes in series approach improves the relative 
recovery of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40, a mathematical method to estimate 
how many probes or microchannels are needed to achieve ~100% recovery was derived.  
Jacobson et al. pointed out that the mass transfer coefficient (k) of any molecule can be determined 
experimentally during microdialysis sampling by measuring its recovery at different flow rates and plotting 
the results to find the slope (kA) using the following approach:1 a) Since  𝑘A(n) = (
1
Rd + Rm+Rq
) , Equation 
1.4, where A is surface area of the probe and n is the number of probes, b) Equation 1.2 (Bungay’s 
equation2), RR = 1 − exp {
−1
Qd(Rd+Rm+Rq)




), and rearranging “c” we obtain d) 𝒌𝐀(𝐧) = [−𝐥𝐧(𝟏 − 𝐄𝐄)]𝐐𝐝 , Equation 1.6. This equation can 
be used if (1-RR) ≠ 0. By plotting –ln(1-RR) vs. Qd-1 the values of kA or the slope regardless of the surface 












Figure 4.1. Estimation of kA for FITC-40 using Equation 1.6 and Jacobson’s approach.1  
























The value of kA was determined for methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40. This was done 
by calculating their relative recoveries using one microdialysis probe at different flow rates (0.8, 1.0, 1.5 
µL/min) and plotting the results, see Figure 4.1. The mass transfer coefficient, kA, of each compound was 
determined experimentally using a CMA/20 microdialysis probe. Then kA was multiplied by n or the number 
of probes to estimate the recoveries using Equation 1.6. These estimations were compared to the 
experiments conducted on Chapter 3. 
 Results and discussion 
The theoretical estimations agreed with the experiments for methyl orange, Figure 4.2, and FITC-4, 
Figure 4.3. For example, the deviation from experiments of methyl orange was -1% (underestimation) and 
+15% (overestimation) for FITC-4 using four probes in series at 0.8 µL/min. However, the theoretical 
estimations started deviating from experiments at a molecular weight of ~10,000 (FITC-10). The deviation 
from experiments using four probes in series at 0.8 µL/min for FITC-10 (Figure 4.4), FITC-20 (Figure 4.5), 












Figure 4.2. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM methyl 
orange at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and 
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Figure 4.3. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC-
4 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and 












Figure 4.4. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC-
10 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and 
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Figure 4.5. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC-
20 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4.n = 3 and 












Figure 4.6. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC-
40 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and 
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As the molecular weight increases the deviation increases. One of the reasons for the deviation could be 
fluid loss. For instance, collections of methyl orange conducted at 5.0 µL/min using 4% dextran-70 as 
perfusion fluid yielded fluid losses of +8% (control), -1%, -11%, and -28% for zero (control or one probe), 
one, two, and three probes connected in series respectively, see Table 4.1. This means that the 
backpressure increases as the number of probes in series increases. More fluid was loss for the four probes 
(-28%) in series compared to one probe (+8%), two (-1%) and three probes (-11%).  







The product kA (Figure 4.1) was determined for one probe and multiplied by the number of 
microdialysis probes (n) connected in series used for the experimental data. It was assumed that the 
system, in terms of hydraulic pressure, did not change from having one probe to two, three, and four probes 
in series. In other words, the product kA was the same for each system or probes connected in series (kA1 
= kA2 = kA3 = kA4). The product kA1 was the slope of the curve that was determined using one probe or 
control. After looking at the data and the system more closely a different approach to estimate the relative 
recoveries was used. The product kA was determined for each “system” individually (one probe = kA1, two 
= kA2, three = kA3, and four probes = kA4). Which means that the product was different for each setting 
used (kA1 ≠ kA2 ≠ kA3 ≠ kA4). This was done to take into account the fluid loss of each system. For example, 
the product kA was determined for one probe and compared the estimated relative recovery versus the 
experimental relative recovery of one probe. After connecting another microdialysis probe in series, the 
product kA2 was determined for that system. This was done for up to four probes (kA4) connected in series. 
Each probe or probes in series was treated as an individual system. The estimations and experiments 
agreed considerably after using this approach, see Figure 4.7. It can be seen by comparing Figure 4.6 (kA1 
= kA2 = kA3 = kA4) with Figure 4.7 (kA1 ≠ kA2 ≠ kA3 ≠ kA4) a significant improvement on the agreement.  









It is good to point out that for the microfluidic system (chapter 5) that was developed based on the 
microdialysis probes in series approach, the kA value would be determined for the entire system not 










Figure 4.7. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC-
40 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. The 
estimations were done using kA for each system individually (kA1 ≠ kA2 ≠ kA3 ≠ kA4). n = 3 and average ± 
standard deviation 
 
4.2.1 Methyl orange 
Using the kA value found in Table 4.2, the relative recovery (RR) for methyl orange was estimated 
to be 44.6%, 58.8%, and 67.0% at the 1.5, 1.0, and 0.8 µL/min flow rates, respectively, see Figure 4.2. The 
estimated RR for four probes was 91% or greater for all three perfusion fluid flow rates.  The lower flow 
rates were estimated to achieve nearly 100% RR with four microdialysis probes in series.  Compared to 
our experimental data (48.9%, 61.3% and 66.7%), this estimation is within (5%) of our experimental results 
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Table 4.2. Measured mass transfer (kA) values of 100 µM solutions of methyl orange, FITC-4, FITC-10, 
FITC-20, and FITC-40 using one CMA/20 microdialysis probe, slope of -ln(1-RR) vs. Q-1 at 0.8, 1.0, and 
1.5 µL/min flow rates. 
Solute used kA (µL/min) R2 
Methyl orange 0.8869 0.9995 
FITC-4  0.2884 0.9783 
FITC-10 0.1822 0.9972 
FITC-20 0.1257 0.9996 
FITC-40 0.0483 0.9996 
 
Using the kA value, from the table above (Table 4.2), and Equation 1.6, the number of probes 
needed to reach 99% relative recovery (RR) for methyl orange was calculated using different perfusion fluid 
flow rates.  These values are shown in Table 4.3 and show the expected flow rate dependence with needing 
only four probes at 0.8 µL/min and 8 probes at 1.5 µL/min to reach 99% relative recovery. Since lower flow 
rates have greater residence times, it would be expected that fewer probes are necessary to achieve 99% 
RR.  
Table 4.3. Estimation of the number of probes needed (in series) to reach 99% relative recovery.  
 Flow rate (µL/min)  
0.8 1.0 1.5 
Solute used  




FITC-4 12 15 22 
FITC-10 19 24 35 
FITC-20 27 34 51 
FITC-40 70 87 131 
 
4.2.2 FITC-4 
Using the mass transport coefficient, kA, found in Table 4.2, the estimations for FITC-4 RR through 
one microdialysis probe were 17.5%, 25.0%, and 30.3% at the 1.5, 1.0, and 0.8 µL/min flow rates. The 
estimated RR for four probes was of 54% or greater. Compared to the experimental data (22.2%, 30.8% 
and 34.1%), these estimations are in general agreement with our experimental results indicating that 
Equation 1.6 can be used to estimate RR for FITC-4.  For FITC-4, the number of estimated microdialysis 
probes in series needed to reach 99% RR using the kA value in Table 4.2 was found to be 12 at 0.8 µL/min 





The experimental data significantly deviated from the calculated relative recovery (RR) estimations for 
FITC-10.  Unlike methyl orange and FITC-4, the estimates of RR started significantly deviating from 
experiments for 3 (49.5% vs. 35.5% at 0.8 µL/min) and 4 (59.8% vs. 39.4% at 0.8 µL/min) probes connected 
in series. The reason for this deviation could be that for larger molecules fluid loss has a greater influence 
on RR than for smaller molecules. In other words, the combination of outward convection combined with 
diffusion toward the dialysis membrane lumen may significantly affect the recovery of larger molecular 
weight solutes. The model used in Equation 1.6 assumes that fluid loss does not change with the number 
of probe added in series. 
4.2.4 FITC-20 
For FITC-20, the estimated relative recovery deviated from experimental observations for 2 (27.0% vs. 
15.9% at 0.8 µL/min), 3 (37.6% vs. 17.2% at 0.8 µL/min), and 4 (46.6% vs. 18.7% at 0.8 µL/min) probes in 
series. Again, it is likely the convective force is greater than the diffusive force for collection of this larger 
molecular weight solute.   
4.2.5 FITC-40 
As with FITC-20, the RR% estimations for FITC-40 deviated from experimental observations for 2 
(11.4% vs. 6.0% at 0.8 µL/min), 3 (16.6% vs. 6.6% at 0.8 µL/min), and 4 (21.5% vs. 7.7% at 0.8 µL/min) 
probes in series. The likely cause is the convection out of the dialysis probes at the higher probe numbers.    
 Conclusions 
 A model to predict the number of microdialysis probes connected in series necessary to achieve ~ 
99% relative recovery was developed. This model was used to estimate the number of probes connected 
in series at different flow rates to achieve near equilibrium between the outer part of the microdialysis probe 
membrane and the inner part. This work served as a basis for the development of a microfluidic system for 
the collection of biomolecules. This is going to be cover in more detail in chapter 5. Additionally, one could 
envision using this approach to get an estimate of in vivo concentrations and use it periodically within 




To continuously run with multiple probes will certainly reduce temporal resolution, but again it could be used 
at the start and completion of an in vivo experiment to gain important information about biological 
concentrations, without using the cumbersome in vivo calibration methods for microdialysis sampling 
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5 Chapter 5.   Miniaturization of microdialysis probes in series method: Design, 
microfabrication, and testing of microfluidic device 
    Introduction 
After demostrating in chapter 3 that the microdialysis probes in series method improves the relative 
recovery of different chemical compounds (methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40), the 
next step was to miniaturize the concept of extending the fluid path length into a microfluidic device. The 
general idea was to make a prototype on polydimethylsiloxane (PDMS) similar in shape as a commercially 
avaible microdialysis probe, see Figure 5.1. As previously stated in this dissertation there is a growing 
interest in miniaturizing microdialysis sampling technique into microfluidic systems.1, 2, 3 However, this in 
most cases can be challenging. One of the main problems is the difficulty of incorparating pumping, valving, 
and detection systems into microfluidic devices due to their large volume to flow rate ratio between their 
components.1 Section 1.2.1.1 covered this topic in more detail. Several steps were taken to miniaturize the 
microdialysis probes in series method into a microfluidic device. First, AutoCAD® computer-aided design 
and drafting software was used to design the microfluidic device and the photoplot. The dimensions of the 
design were chosen based on different factors: a) Cost of the photoplot (the smaller, ~10 µm, the features 
the more expensive the photoplot), b) previous experience working with microchannels of similar size, c) 

























The microfluidic device developed for this dissertation had the following dimensions: 1) Overall length of 
44.0 mm (1.7”), 2) overall height of ~100 µm, 3) nine microchannels with different widths to reduce 
backpressure, one of 40 µm (inlet), six of 50 µm (collection area), and two of 100 µm (outlet) respectively, 
and 4) the length and width of the collection area were 4.4 mm and 2.0 mm. Finally, standard 
microfabrication techniques were used. 
    Experimental section 
5.2.1 Photoplot 
Figure 5.2 shows a 2D drawing of the microfluidic device. A negative photoplot was ordered in-
house from the University of Arkansas High Density Electronics Center (HiDEC). According to Varteresian, 
“A photoplot is nothing more than a high quality transparency, or view graph.”4 This means that some areas 
of the photoplot would allow ultraviolet (UV) light to pass through it and other would not. The areas expose 
or that allow UV to pass through it would be polymerized during the photolithography process. It is good to 













Figure 5.2. 2D drawing of the microfluidic device. This drawing is not to scale to facilitate the visualization 




The drawing used to order the photoplot was designed for a 4” in diameter silicon wafer. Five replicas could 
be made at the same time using this photoplot. After receiving the negative photoplot a SU-8 master mold 
was fabricated.  
5.2.2 Microfabrication of PDMS replicas 
A master mold was fabricated using a similar procedure (Figure 5.3) previously used by the author 
of this dissertation.5 Standard photosensitive polymers, SU-8 50 and SU-8 3050, from MicroChem Corp., 
Westborough, MA were used to make the master mold. Both SU-8 50 and SU-8 3050 were used due to 
their in-house availability and the height of the channels (~100 µm). These two polymers can be used 
interchangeably. The SU-8 50 was purchased from MicroChem and the SU-8 3050 was available at HiDEC. 
The main difference between SU-8 50 and SU-8 3050 is the thickness that can be achieved during spin 
coating. SU-8 50 thickness ranges from ~40 µm to ~120 µm, whereas SU-8 3050 thickness ranges from 
~45 µm to ~102 µm according to their data sheets.6 Both photoresist resins can achieve the thickness range 
chosen for this work. To accomplish the desire thickness or overall height of the microchannels the 
MicroChem data sheet for SU-8 3000 permanent epoxy negative photoresist was followed.6 A long pass 
optical filter (PL-360-LP) from Omega Optical, Inc, Battleboro, VT was used to eliminate UV radiation below 
350 nm as recommend by the SU-8 3000 data sheet.6 This optical filter was placed on top of the negative 
photoplot during the exposure step of the master mold. It was found that when the optical filter was not 
used during the master mold fabrication some SU-8 residues were observed after the development step 
(under development). This was due to the incomplete photopolymerization of the SU-8 during the exposure 
step. The permanent epoxy negative photoresist, SU-8, undergoes a phase change during 
photopolymerization. Due to the fact that a partially polymerized SU-8 is not soluble in the MicroChem’s 
SU-8 developer solvent and a non-polymerized SU-8 is can be used as an indicator of incomplete 
photopolymerization. The SU-8 required more energy to complete the chemical reaction and change from 
liquid to solid after photopolymerization. It is good to note that the exposure time was increased by 40% as 
recommended by MicroChem data sheet for SU-8 3000.6 The latter in terms increased the amount of energy 
applied to the SU-8 during photopolymerization (UV exposure). Figure 5.4 shows the SU-8 master mold 





After the inspection, PDMS replicas were made using the master mold and following the procedure shown 
on Figure 5.3. To close the open channels on the replicas, PDMS lids were made using a silicon wafer. 
These lids were basically flat pieces of PDMS with and without indentations, see Figure 5.5. 
Figure 5.3. Standard microfabrication process used to make the PDMS replicas.5 MicroChem’s SU-8 
developer was used instead of propylene glycol.6 
 
Glass slides were used as lids for some of the preliminary devices. The advantage of using glass slides 
during microfabrication is that they reversibly stick to PDMS. Van der Waals forces at the surface of glass 
and PDMS form a weak reversible bond between them. It is only necessary, in most cases, to bring both 
surfaces together to achieve the reversible bond. This allowed the PDMS replicas to be tested using flow 
rates of up to 5.0 µL/min without any surface modification, see Figure 5.6. The PDMS was made using the 
standard Sylgard® 184 Silicone Elastomer Kit from Dow Corning Corporation, Midland, MI. The kit contains 
a base and curing agent that are typically mixed to a 10:1 ratio by weight. The ratio used for all the PDMS 
microchannels and lids fabricated was 10:1. The inlet and outlet of all the PDMS replicas were made using 
a round punch of 0.71 mm cutting edge diameter purchased from Technical Innovations, Inc., Angleton, 




This was done when the inlet or outlet broke during the punching process (Figure 5.24, “C” or device on 














Figure 5.4. SU-8 master mold in a wafer transport box after microfabrication. Up to five PDMS replicas at 





























Figure 5.6. Testing of an uncut PDMS replica under a light microscope using a glass slide as a lid. The 






















Figure 5.7. Round punches used to make the inlet and outlet of the PDMS microfluidic devices. The 
highlighted areas show their cutting edges. The round punch of 0.71 mm cutting edge diameter is shown 
on a) and the punch of 3.02 mm is shown on b).  
 
Each PDMS replica (open channels) was tested under a light microscope using a glass slide as a lid and 
either 10 mM PBS pH 7.4 or HPLC water at a flow rate of 5.0 µL/min unless otherwise stated, see Figure 
5.6. This was done before proceeding to bind the PES filters and PDMS/glass lids to the PDMS replicas. 
Testing the PDMS replicas saved time and money and made sure that none of the microchannels within 




5.2.3 Microfabrication of microfluidic devices 
To reach the final working microfluidic device, five assembly iterations were performed. Figure 5.8 
shows all the assembly approaches that were used. Each of the assembly’s procedures and how they lead 
to the next procedure will be addressed in detail later in this section. The membrane chemical composition, 
polyethersulfone (PES), was chosen based on the CMA/20 microdialysis probes used in this dissertation 
(Chapters 2 and 3) since they have a PES membrane. As proof of principle Whatman™ Puradisc PES 
syringe filters of 25 mm in diameter and pore size of either 0.2 µm or 0.45 µm were used from Sigma-
Aldrich, St. Louis, MO. The problem with using these syringe filters was that in order to retrieve the 
membrane from the plastic case it has to be broken. Figure 5.9 shows the PES syringe filter before and 
after retrieving the PES filter. Some of the grooves on the plastic case of the PES syringe filters were 
present on the PES filter after retrieving them, see Figures 5.18 and 5.19. However, the PES filters were 
very useful to test the effectiveness of the bonding method described by Aran et al. shown on Figure 5.10.7 
Following this method, the PES filters (membranes) were treated for 1 min at a pressure of 600 mTorr and 
100 W of power in an Automated Plasma Cleaning System (APE 110), see Figure 5.11. After both sides of 
the membranes were treated, they were placed in a 5/95 (v:v) APTES:H2O solution of 3-amino 
propyltriethoxysilane (APTES) at 80°C for 20 min. This solution was made using 99% (in water) v/v APTES 
stock solution purchased from Sigma-Aldrich, St. Louis, MO. The PDMS replicas and their lids (Figure 5.12) 
were treated in the APE 110 using the same parameters, but for a shorter period of time (20 s). It was found 
that when silicon wafers were used (Figure 5.11 vs. Figure 5.12) after the plasma treatment, the PDMS 
replicas and lids weakly attached to the wafers. This caused some problems, since they had to be physically 
removed from the wafers leading to breakage in some instances. Regular office Scotch™ tape was used 
to fix this problem. The silicon wafer was covered with the tape to prevent PDMS from binding to the wafer. 
After the 20 min in the 5% (in water) v/v APTES solution the membranes were let dry and were brought 
together to the PDMS replicas and lids. They were incubated for at least 24 hours having either a weight of 
~6 pounds (Fisher Scientific Catalog 2008/09) on top or pressed using a c-clamp of 3” (Figure 5.13)  to 
ensure a stronger bond.7 When the c-clamp was used care was taken to make sure the microfluidic device 
was not bent or broken (glass lid). This was accomplished by placing pieces of PDMS on both sides of the 






Figure 5.8. The five different assemblies (1-5) that were done before reaching to the final device (6): 1) 
Glass slide was used as lid and chemically bound on top of the PDMS replica next to the PES (filter) 
membrane (side by side), 2) same as 1), but PDMS was used as a lid, 3) PDMS lid was chemically bound 
to the PDMS replica and the membrane, but one of the etches of the lid was physically pushed on top of 
the etch of the membrane, 4) an indentation was made in the glass lid by drilling it and chemically bound 
on top of the PDMS replica and membrane, 5) same as 4), but the indentation was made on PDMS during 
curing, and 6) PES membrane was chemically bound the PDMS replica completely covering the replica 






















Figure 5.10. Aran et al. bonding method used to bind the PES filter to the PDMS prototype.7 Reproduced 


















Figure 5.11. Oxygen plasma instrument used to chemically modify the surface of PDMS replicas and PES 




















The advantage of Aran et al’s method was its simplicity and strength of the bond formed between the PDMS 
and the PES membrane. One of the drawbacks of this method is the 24 hours waiting time which is longer 
(48 hours) when glass is used. The devices were tested using either HPLC grade water or 10 mM PBS pH 
7.4 at 5.0 µL/min unless otherwise stated. To evaluate the quality of the bonding between PDMS and PES 
membrane the devices were observed under a light microscope with and without a camera to see if any 
leaks were present during perfusion, see Figure 5.14. Before the first assembly was made a simple PDMS 
microfluidic device was fabricated to test the Aran et al’s binding method. The device consisted of one 
straight channel of 100 µm in width and 100 µm in height, see Figure 5.15. The PES filter was used as a 
lid and bound on top of the channel. Two pieces of PDMS were chemically bound at both ends of the 
channel (inlet and outlet). 
A simple pull test was conducted to evaluate the strength of the bond between the PES filter and 
the PDMS channel. The simple pull test consisted of pulling off the PES filter after the 24 hours incubation, 
see Figure 5.16. After successfully evaluating the binding method, the first assembly approach was made. 











Figure 5.13. Setup used during the 24 or 48 hours incubation showing a microfluidic device pressed on the 

















Figure 5.14. Setup used to inspect the microfluidic devices after microfabrication. The left side shows the 
perfusion fluid flowing in the channel having the PES membrane at the bottom. The microfluidic device 
shown in this picture corresponds to the simple microfluidic device of one channel made to test Aran et al’s 




























Figure 5.16. PDMS microfluidic device during simple pull test. Filter traces indicated the strength of the 
















Figure 5.17. Cut PDMS replica with open channels and filter bound on collection area. 
 
 
 First assembly approach glass lid side by side 
The first assembly approach used was made using a glass slide as lid and a syringe PES filter. As 
shown on Figure 5.8 1), the PES filter was first bound to the PDMS channels. After that the glass lid was 
chemically bound to the PDMS channels. The glass lid was positioned on top of the channels so that the 





As mentioned before, the glass, PES filter, and PDMS were chemically bound using the Aran et al’s 
procedure described on section 5.2.3. The microfluidic device was tested using HPLC water at a flow rate 
of 2.0 µL/min. The region between the PES filter and glass lid, “union region” (Figure 5.18 and 5.19), was 
where leakage occurred. To eliminate the leakage in the union region another assembly approach was 
made. 
 Second assembly approach PDMS lid side by side 
The second assembly approach used was similar than the first approach, but PDMS was used as a lid. The 
idea of using PDMS was to have a more flexible material. Glass is more rigid than PDMS and that difference 
could cause microgaps, see Figure 5.20. Bhattacharya reported that when glass and PDMS are chemically 
bound a higher gap between the surfaces is formed.8 On the other hand, the opposite was found when two 
PDMS surfaces were bound. Based on this finding, PDMS was used as a lid for this assembly. The same 
binding procedure as the first assembly (5.2.3.1) was used. After testing the device with HPLC water at 1.0 
µL/min the same leakage was found as the first assembly. The device was leaking through the union area. 











Figure 5.18. Microfluidic device during quality inspection under light microscope. This was the first 














 Figure 5.19. First assembly approach used during the development of the microfluidic device showing 













Figure 5.20. Diagram showing how microgaps could be formed when PDMS and glass are bound versus 
PDMS and PDMS according to Bhattacharya. Redrawn from reference 8.  
 
 
 Third assembly approach PDMS lid on top edge 
This assembly approach consisted of the same components as second assembly (5.2.3.2), but the 
PDMS lid was bound at the edge of the PES filter. The idea was to apply a high pressure to a flexible PDMS 
lid positioned at the edge of the PES filter, see Figure 5.8 3), during binding incubation to increase the 
contact surface between the PES filter and PDMS lid. The PDMS curing time and temperature were 
reduced from 1 hr to 30 min and 75°C to 70°C respectively. These changes were made to have a more 
flexible PDMS. For this approach the c-clamp setup was used, see Figure 5.13. The device was leaking 




The leakage was found in the same union area. This assembly approach led to a fourth assembly with the 
same purpose of eliminating the leakage and be able to conduct collection experiments. 
 Fourth assembly approach glass indented 
To solve the leakage problem, another assembly approach was performed. This approach 
consisted of using glass as a lid having an indentation of approximately 2 mm by 2 mm and depth of 60 µm 
(thickness of PES filter). The indentations were made on glass slides using a rotary diamond drill bit of 
3/16”. Water was used as lubricant to minimize friction. The diamond drill bit was mounted in a benchtop 
drill press. The pressure applied during drilling was controlled manually. A piece of PES filter was cut and 
used to verify the depth of the indentation.  
When the indentation matched the thickness of the PES filter, the indented glass lid was used for the 
assembly. Figure 5.21 shows the microfluidic device before binding incubation. Two glass slides (without 
indentation) were used during incubation. One under the PDMS channels and the other on the PES filter 
next to the indented glass slide. This was done to ensure that the pressure was evenly applied during 
binding incubation. For this assembly, the c-clamp of 3” was used as well, see Figure 5.13. The device was 
leaking when it was tested after binding incubation under the same conditions as the third assembly. Since 
the manual drilling process added more variations to the assembly approach, another assembly approach 














 Fifth assembly approach PDMS indented 
This new assembly approach was similar than the previous assembly (5.2.3.4), but the glass lid 
was replaced for PDMS, see Figure 5.8 5). For this approach the indentation on the PDMS lids were made 
by placing pieces of PES filter (larger than the collection area) on a 4” silicon wafer having cardboard taped 
around it. The PES filter pieces were cut larger than the collection area to make sure that the indented 
PDMS lids were wider. This was done to minimize leakage. To ensure the uniformity of the indentation, the 
PES filter pieces were glued using LOCTITE® super glue (gel control) to the wafer.  
A thin layer of super glue was applied on the silicon wafer. To achieve a thin layer, a drop of the super glue 
was placed on the wafer and scraped using a metal blade. This ensured that a thin layer of super glue was 
used. After the super glue was applied on the wafer, three PES filters of 5 mm in height and 2 mm in width 
were placed on the wafer. This served as a mold for the PDMS lids with indentation. The Sylgard® 184 
Silicone Elastomer Kit was used to make the PDMS lid replicas on the mold (see section 5.2.2). The mold 
with PDMS was incubated in an oven at 75 C° for 1 hour. After binding incubation, the three PDMS lids with 
indentation were cut, see Figures 5.22 and 23. Before binding each part (PDMS lid with indentation, PES 
filter, and PDMS channels), each device was assembled to make sure they fit well, see Figure 5.24. All 
three microfluidic devices (Figure 5.24) were tested using 100 µm methyl orange solution and 4% dextran-
70 in 10 mM PBS pH 7.4 or HPLC water as perfusion fluid. The inlet of one of the devices (Figure 5.25 “C”) 
was expanded using a punch of 3.02 mm cutting edge diameter. This was done to eliminate the leakage 
present in the inlet during perfusion. A plastic fitting was glued to the inlet using LOCTITE® super glue. To 
seal the other side of the inlet, a piece of PDMS was glued at the bottom of the plastic fitting, see Figure 
5.25. The microfluidic device was leaking from the collection area (Figure 5.26) and was fixed with super 
glue. After fixing the leakage using super glue flow rate verification was conducted. The flow rate was 
verified using methyl orange and 4% dextran as perfusion fluid. This verification was done by collecting 
three samples from the outlet every 2 min at 2.0 µL/min and measuring their weight. A regular BASi syringe 


















































































Figure 5.26. PDMS microfluidic device made using fifth assembly during leakage testing using 100 µM 





For the gravimetric calculations, it was assumed that the density of the dialysate was 1.0 g/mL (the density 
of 100 µM in HPLC was previously determined, Chapter 3, to be 0.998 g/mL ± 0.004 g/mL). The calculated 
volume was 4.0 µL (collection time multiplied by flow rate). After collections, the measured flow rate or 
volume delivered overtime was 4.14 µL ± 0.19 µL. This result indicates a fluid gain of 3.5%. Since a larger 
fitting (Figure 5.25) was glued to the inlet, an in-house made tubing connection was used, see Figure 5.26 
and 5.27. Two types of experiments were performed. The first experiment was performed by placing 7 mL 
of the methyl orange solution in a 20 mL beaker, a recovery experiment (Figure 5.27), and using 4% dextran 
as perfusion fluid pumped at a 2.0 µL/min rate. The second experiment was a delivery experiment in which 
the methyl orange solution was placed in the syringe of the BASi syringe pump system. The latter 
experimental setup can be seen on Figure 5.28. The flow rates used was this experiment 1.0 µL/min. No 
recovery or delivery was observed during these experiments. This was determined by measuring the 
absorbance of the dialysate using the NanoDrop 2000 UV-Vis spectrophotometer from Thermo Scientific 
(Wilmington, DE), data not shown here. Since super glue was used to fix the leakage from the membrane 
(Figure 5.26), this could have clogged the pores of the membrane. The super glue could have diffused into 
the pores clogging them. A microgap was found in the microfluidic devices explaining why the devices were 


































The other two devices (Figure 5.24 “A” and “B”) were leaking as well after testing with HPLC water at 0.5 
µL/min and 1.0 µL/min respectively. Figure 5.30 shows microfluidic device “B” during leakage testing. Unlike 
microfluidic device “C”, the other two devices’ inlet and outlet were made using a 0.71 mm round punch. 
This facilitated the tubing connections. The next logical step would have been to conduct this assembly 
approach under a microscope to make sure that microgaps were not present. However, one last assembly 
approach was developed to eliminate all the problems with the leakage. Before conducting this last 







Figure 5.29. Microgap formed after assembly approach number 5 was used. This microgap was located at 















Figure 5.30. Microfluidic device made using assembly number 5 been tested using HLPC water under a 
light microscope. 
 
5.2.3.5.1 Equilibrium dialysis 
To evaluate whether or not analyte transport was occurring across the PES filter an equilibrium 
dialysis experiment was conducted. A micro-equilibrium dialyzer of 25 µL from Harvard Apparatus 
(Holliston, MA) was used, see Figure 5.31. In one chamber 25 µL of 10 mM PBS pH 7.4 were pipetted and 
in the other chamber the same volume of 100 µM methyl orange (diluted in the same buffer) was placed. 
The total volume used was 50 µL. A Whatman™ Puradisc PES syringe filter of 25 mm in diameter and pore 
size of 0.2 µm purchased from Sigma-Aldrich, St. Louis, MO was used. As previously mentioned the syringe 
filter was broken to retrieve the filter. After retrieving the filter, it was cut using a regular office scissors to 
the size of the chamber. The micro-equilibrium dialyzer was placed horizontally (as shown on Figure 5.31) 
on a bench for 1 hour and 22 minutes at room temperature. The concentration of methyl orange in each 
chamber was measured using an UV-Vis spectrophotometer (NanoDrop) after incubation. The results were 
reported as percent recovery. The measured concentrations of methyl orange were related to the initial 
concentration of methyl orange used (100 µM). It was found that a 49.7% of methyl orange was present in 
chamber 2 and a 41.4% in chamber 1. These results showed that transport across the PES filter occurred 








Figure 5.31. Schematic representation of the micro-equilibrium dialyzer used for the equilibrium dialysis 
experiment performed to test the PES filter transport. 
 
 
 Sixth assembly approach using UE50 membrane 
The last assembly approach used to solve the leakage problem with the microfluidic system was 
conducted, see Figure 5.8 6). This assembly approach consisted of covering the PDMS replica with open 
channels using a PES membrane and used a flat PDMS as a lid. The collection area was only covered with 
the PES membrane to allow the transport of molecules across it. The idea was to eliminate the need for 
indentations or precision alignments during assembly. The sixth approach significantly simplified the 
microfabrication of the microfluidic device. To test this approach, TriSep UE50 flat-sheet polyethersulfone 
(PES) ultrafiltration membrane of 100 kDa (MWCO) from Sterlitech Corporation, Kent, WA was used. This 
flat-sheet membrane had two distinct roughness in each side. One side was called “shiny” and the other 
side “dull”. The latter had a hair-like roughness, see Figure 5.32. According to Sterlitech, this difference is 
caused by their manufacturing process. They stated that the “shiny” side indicates tighter pores. This 
difference caused a problem during the microfluidic device assembly and will be addressed later in this 
section. The PDMS channels, PDMS lids, and PES membranes were attached chemically using the Aran 
et al’s binding method (Figure 5.10 and 5.11). After the plasma and APTES treatments the “dull” side (Figure 
5.32) of the PES membrane did not bind to the PDMS lid as the “shiny” side of the membrane. As soon as 
the “shiny” side of the membrane and PDMS channels were brought into contact a bond was formed. The 
same observation was reported by Aran et al (7). As previously mentioned, the “dull” side of the membrane 





















Figure 5.32. PDMS microfluidic device made using TriSep UE50 flat-sheet PES membrane. The roughness 
of the “dull” side can be seen in this picture. A glass slide was used to carry the device. 
 
When the “dull” side and PDMS lid were brought into contact, they did not form a bond. This was visually 
observed as both parts did not attach or fell apart. To fix this problem, the surface of the “dull” side of the 
membrane and PDMS lid were treated using the APE 110 oxygen plasma at 600 mTorr and 100 W for 20 
seconds. To increase the oxygen exposure to the surface and activate the surface. After one trial, the 
membrane and PDMS lid formed a bond and were incubated accordingly to ensure that a stronger bond 
was achieved. Figure 5.33 shows one of the four PDMS microfluidic devices made using the new 
membrane during leakage inspection. The microfluidic devices were inspected for leakage under a light 
microscope by pumping a solution of 10 mM PBS pH 7.4 at a 1.0 µL/min rate, see Figure 5.33. During this 
test the flow rate from the outlet of one of the microfluidic devices was measured gravimetrically. Two 




It was assumed that the PBS density was 1.0 g/mL. Based on this assumption, the average (n = 2) amount 



















Compared to the delivered theoretical volume of 5.0 µL, calculated using the collection time and pumping 
rate, the delivered measured volume (4.7 µL) was only 0.3 µL off. This indicated that only a small amount 
of fluid was loss across the membrane. After inspection, the devices were tested using 0.9 mM methyl 
orange in HPLC water as the analyte and PBS as perfusion fluid. Recovery and delivery experiments were 
performed on the devices. For the recovery experiments, the methyl orange was placed in either a 20 mL 
glass beaker (Figure 5.34) or a plastic petri dish (Figure 5.35). The methyl orange solution was placed in 
the syringe during the delivery experiments, see Figure 5.36. Of the four devices, two devices broke apart 
(Figure 5.37). After the 24 hours binding incubation, the PDMS lids came off. This indicated that a very 
weak bond was formed between the PES UE50 membranes (“dull” side) and PDMS lids. However, the 















Figure 5.34. Experimental beaker set up used for recovery experiments performed on the PDMS 






Figure 5.35. Recovery experiments performed using a plastic petri dish on the PDMS microfluidic devices 


















Figure 5.36. PDMS microfluidic device (UE50 PES membranes) during methyl orange delivery experiment. 







Figure 5.37. PMDS microfluidic devices after binding incubation using UE50 PES membranes. The PDMS 
lids detached from the PES membranes. 
 
 
These microfluidic devices were further tested as previously mentioned by either recovering methyl orange 
or delivering it in the device (Figures 5.34, 5.35, and 5.36). The recovery experiment conducted at 1.0 
µL/min for 7 hours and 31 minutes, yielded dialysates not detectable by the NanoDrop 2000 UV-Vis 
spectrophotometer. Figure 5.38 shows physical appearance of the UE50 PES membrane after the recovery 
experiment was conducted. The fact that a lack of orange color was observed (see Figure 5.36 for color 
reference), could indicate that transport across the membrane was very poor or at an undetectable level 
(absorbance ≤ blank = PBS).  After this result, the delivery experiment was conducted. The microfluidic 
device was placed in a beaker containing PBS and a methyl orange solution of 0.9 mM was delivered at a 
pumping rate of 5.0 µL/min into the device. A higher flow rate (1.0 µL/min vs. 5.0 µL/min) was chosen for 
the delivery experiment (Figure 5.36) to increase the amount of methyl orange delivery across the 
membrane. The same result as the recovery experiment was found. The dialysates measured 
spectrophotometrically were below the limit of detection. The orange marks shown on Figure 5.36 indicates 
that the methyl orange was flowing in the microfluidic channels and not leakage was present. One of the 
reasons why methyl orange was not detected during the delivery experiments, could be dilution. The 













Figure 5.38. PDMS microfluidic device showing the wettability of the UE50 PES membrane during recovery 
experiments. This was one of the indications of poor transport across the membrane. 
 
 
To elucidate whether the problem was the transport across the membrane or not, the UE50 PES membrane 
was tested using the equilibrium dialysis technique (see section 5.2.3.5.1 for details). This experiment was 
conducted by Dr. Sarah Phillips. According to Phillips, the equilibrium dialysis experiment was conducted 
using a solution of 200 µM FITC-10 diluted in ringer. She found that the recovery of FITC-10 after 13 hours 
and 30 minutes was ~6%. The equilibrium dialysis experiment of FITC-10 led to a new and final PES 
membrane. The sixth and final assembly approach was chosen as the more effective to make the 
microfluidic device, since not leakage was observed during testing or experiments. Nevertheless, the 
microfluidic devices made with the UE50 membranes did not work on either recovery or delivery mode. To 
solve both the membrane transport and membrane-PDMS binding problems, a new PES membrane was 
selected. The experiments conducted in the section were instrumental for the development of the 
microfluidic device. One important finding was how the roughness of the PES membrane surface affected 
the strength of the chemical bond formed between the membrane and PDMS. The next section will cover 







5.2.3.6.1 Sixth assembly approach using PES019025 membrane 
After six assembly iterations, the problem with the leakage found in the microfluidic devices was 
solved. The problem was solved by having a PES membrane covering the microfluidic channels of the 
device. This approach was simple and significantly reduced the need to have a precise assembly when 
only the collection area was covered in previous assemblies. However, for future further developments of 
the microdialysis-based microfluidic device engineered during this dissertation, the amount of PES 
membrane should be used reduce to minimize cost. Chapter 6 will cover the latter in more details.  
 Materials and methods 
Flat polyethersulfone (PES) membrane filters of 90 mm in diameter and pore size of 0.1 µm were 
purchased from Sterlitech Corporation, Kent, WA. The thickness of the membrane was ~150 µm. This was 
determined using an in-house micrometer. This was within the Sterlitech thickness range for this type of 
membrane (110-150 µm) found on their website.9 A solution of 5% (in water) v/v of 3-amino 
propyltriethoxysilane (APTES) was made using 99% v/v APTES stock solution purchased from Sigma-
Aldrich, St. Louis, MO. The 5% v/v APTES solution was used to chemically modified the surface of the PES 
membrane during the Aran et al’ binding method (Figure 5.10). This method was previously described in 
detail on section 5.2.3. The transport of 100 µM methyl in 10 mM PBS pH 7.4 solution across of the PES 
membrane was determined using equilibrium dialysis (see section 5.2.3.5.1) after plasma and APTES 
treatments. The solution of methyl orange was placed in one chamber (25 µL) and the PBS was placed (25 
µL) in the other chamber. The micro-equilibrium dialyzer (Figure 5.31) with the solutions was incubated at 
room temperature for 2 hours.  
The microchannels and lids were made using the standard Sylgard® 184 Silicone Elastomer Kit 
from Dow Corning Corporation, Midland, MI. The kit contains a base and curing agent that are typically 
mixed to a 10:1 ratio by weight. This kit was used to make the PDMS and the curing time and temperate 
used were 1 hr and 75 °C. The master mold was made using SU-8 3050 from MicroChem Corp., 
Westborough, MA. The same procured as described on section 5.2.2 was used. The PDMS microfluidic 
device was tested using a BASi syringe pump system (West Lafayette, IN) at pumping rates of 1.0, 2.0, 




The perfusion fluids used were 10 mM PBS pH 7.4 and 4% dextran-500 in 10 mM PBS pH 7.4. The amount 
of dialysate exiting the outlet of the microfluidic device over time was determined gravimetrically. This was 
performed to determine the fluid loss across the membrane. Push-pull experiments were conducted on the 
microfluidic device using a MAB-20 microdialysis pump from Microbiotech, Stockholm, Sweden. The 
following sequence was used for the push-pull experiments to find the optimal setting: a) 1.0-4.0 µL/min, b) 
0.5-4.0 µL/min, c) 0.5-5.0 µL/min, d) 0.2-5.0 µL/min, e) 0.2-3.0 µL/min, f) 0.2-2.0 µL/min, and g) 0.2-1.0 
µL/min. The last setting (0.2-1.0 µL/min) was performed on microdialysis probes having PES membranes 
of 100 kDa MWCO and length 10 mm (CMA/20) and 4 mm (CMA/12) respectively. These microdialysis 
probes were purchased from Harvard Apparatus, Holliston, MA. The analyte used was methyl orange. A 
solution of 0.9 mM methyl orange in HPLC water was used for the experiments. Push or regular 
microdialysis experiments were performed at 0.2 µL/min and 1.0 µL/min on the device. The latter flow rate 
was used for relative recovery experiments performed on a CMA/12 microdialysis probe. The perfusion 
fluid used for push and push-pull experiments was 4% dextran-500 in 10 mM PBS pH 7.4.   
 Theoretical estimations were made to evaluate the difference in fluid transport properties between 
the three systems (microfluidic device, CMA/12, CMA/20). The surface area of the membrane, linear 
velocity, pressure drop, and the resistance to flow were estimated for each system. The log mean surface 
area (𝒮𝓂) was used to estimate the surface of the microdialysis probes.
10 For the microfluidic device, the 
pressure drop was estimated using an aspect ratio (a) of 0.5. Phosphate buffer saline was assumed to be 
the perfusion fluid. A pumping rate of 1.0 µL/min and temperature of 25 °C were also used for the 
estimations. These calculations were performed to further improve the performance of the microfluidic 
device in the future. Table 5.1 shows the equations used for the estimations. It was assumed, for the 
estimations, that the collection area of the device was a straight channel, see Figure 5.39. This was done 









Table 5.1. List of equations used to estimate the fluid transport properties of the three systems. 
 Microdialysis probes Microfluidic device 






 Surface area = width * length 


































(1 − 1.3553𝑎 + 1.9464𝑎2 − 1.7012𝑎3 + 0.9564𝑎4 − 0.2357𝑎5) from reference 11. 













Figure 5.39. Schematic representation of microfluidic device collection area. For the estimations this area 
was assumed to be a straight channel to simplify the estimations. 
 
 Results and discussion  
Analyte transport across the PES membrane was similar as the PES filters (section 5.2.3) first used 
to make the microfluidic devices. After the two hours incubation, the relative recovery was 44.74% ± 0.64% 
(n =3) from the chamber with methyl orange and 43.26% ± 2.22% (n = 3) from the chamber with PBS. The 




The fluid loss across the membrane of the PDMS microfluidic device was 36.10% ± 2.25% (n = 3) when a 
solution of 4% dextran-500 in 10 mM PBS pH 7.4 was pumped into the device at a rate of 5.0 µL/min for 2 
min. On the other hand, a fluid gain of 4.10% ± 0.98% (n = 3) was observed when 10 mM PBS pH 7.4 was 
used. These results indicated that an increment in the internal pressure of the microfluidic device when 4% 
dextran-500 was used. This is due to the viscosity differences between the 4% dextran-500 solution (~1.18 
mPa.s) and PBS (~0.89 mPa.s). A fluid gain is typically observed during regular microdialysis sampling 
experiments. The fluid gain for the CMA/12 microdialysis probe at 1.0 µL/min using 4% dextran-500 in PBS 
as perfusion fluid was 3.37% ± 0.06% (n = 3). The fluid loss across the membrane of the device increased 
with the pumping rate. The fluid loss across the membrane was measured at pumping rates of 2.0 µL/min 
and 1.0 µL/min using 4% dextran-500 as perfusion fluid. It was found that the fluid loss at 2.0 µL/min was 
26.40% ± 3.80% (n = 3) and at 1.0 µL/min was 22.30% ± 2.40% (n = 3). At lower pumping rates the fluid 
loss across the membrane is reduced. This means that the hydraulic pressure generated by the syringe 
pump is smaller. When 4% dextran-500 was pumped at 5.0 µL/min into the device a bubble was observed 
at the collection area, see Figure 5.40. The bubble indicated that a higher internal pressure was generated 
at the pumping rate. The bubble was smaller when slower pumping rates were used (Figure 5.41) and no 
bubble was observed when PBS alone was used. The relative recovery of methyl orange at 0.2 µL/min was 
8.41% ± 0.31% (n = 2) and at 1.0 µL/min was 1.64% ± 0.22% (n = 3). These results showed that the 
microfluidic device was able to collect methyl orange, but that the device needs to be optimized.  
As a comparison, the relative recovery of methyl orange was determined using a CMA/12 
microdialysis probe at a pumping rate of 1.0 µL/min. CMA/12 microdialysis probes have PES membranes 
of 4 mm length and the device has a collection area length of ~4.4 mm. The relative recovery was 30.60% 
± 1.35% (n = 3). One of the reason why the device yielded a lower relative recovery than the microdialysis 
probe could be that the microfluidic device has a thicker membrane. Microdialysis probes have a membrane 
thickness of 50 µm, but that thickness includes the supporting layer. The active layer is of ~5 µm thick. In 
contrast, the thickness of the microfluidic device membrane is ~150 µm. The thickness of the microfluidic 
device significantly reduced the transport across the membrane. Push-pull experiments were performed to 
increase the transport across the membrane based on the latter results. The optimal setting for the 














Figure 5.40. PMDS microfluidic device during flow verification testing using 4% dextran-500 in 10 mM PBS 

































Figure 5.41. Microfluidic device during fluid verification testing at 2.0 µL/min using 4% dextran-500 as 





The relative recovery of methyl orange using this setting was 78.78% ± 2.46% (n = 3). The same setting 
was used on CMA/20 and CMA/12 microdialysis probes. The relative recovery of these probes was 89.38% 
± 0.91% (n = 3) and 88.29 ± 2.88% (n = 3), respectively. The difference in relative recoveries of the 
microfluidic probes and the microfluidic device was significantly smaller during push-pull experiments than 
push experiments. Based on these results it can be stated that the thickness of the membrane is the main 
source for a lower relative recovery as compared to the microdialysis probes. Figure 5.42 shows the relative 
recoveries of the full sequence used for the push-pull experiments performed on the microfluidic device. 
The full sequence was compared to the push-pull recoveries of the CMA/20 and CMA/12 microdialysis 
probes. All the experiments were conducted on uncut microfluidic devices, see Figure 5.43. This was done 
to reduce time and minimize the possibility of breaking the device. Figure 5.44 shows the microdialysis 


















Figure 5.42. Comparison of relative recovery of methyl orange performed on the microfluidic device and 
microdialysis probes (CMA 20 and CMA 12) under different pumping conditions. Note that for push at 0.2 














































































 The results of the estimations, performed to further elucidate the source of variation between the 
relative recovery of the device and the two microdiaysis probes, are shown on Table 5.2. These estimations 
indicated that the microfluidic device had a surface area three and seven times smaller than the CMA/12 
and CMA/20 microdialysis probes, respectively. As previously stated, the surface area of the membrane is 
directly related to the relative recovery. This means that the device could be further improved by increasing 
the surface area of the membrane. The linear velocity and resistance to the flow for the microfluidic device 
were higher than the microdialysis probes. Consequently, the residence time of the device was shorter than 
the microdialysis probes, limiting the relative recovery of the device. Increasing the residence time of the 
collection area in the device could further improve the relative recovery.   
 
Table 5.2. Surface area, linear velocity, pressure drop, and resistance to the flow estimations for the 
microfluidic device, CMA/12 and CMA/20 microdialysis probes. The results of the push-pull experiments 
were added as reference. 













Microfluidic device 4.4 ~2 5 x 10-3 3 x 1012 56 78.78 ± 2.46 
CMA/12 probe 4.0 ~6 8 x 10-4 8 x 1010 8 x 1010 88.29 ± 2.88 
CMA/20 probe 10.0 ~14 9 x 10-4 2 x 1011 2 x 1011 89.38 ± 0.91 
 
 Conclusions 
After multiple iterations (7), a PMDS microfluidic device able to mimic current microdialysis sample 
probes was developed. The microfluidic device was able to collect 8.41% ± 0.31% (n = 2) and 1.64% ± 
0.22% (n = 3) of methyl orange when push experiments were performed at 0.2 µL/min and 1.0 µL/min 
respectively. Compared to the relative recovery (30.60% ± 1.35% (n = 3)) of methyl orange collected using 
a CMA/12 microdialysis probe at 1.0 µL/min and under the same conditions, the relative recovery of methyl 
orange from the device was very low. This indicates that the microfluidic device is collecting molecules, but 
still needs to be optimized. One of the sources of the devices poor performance could be the thickness of 
the PES membrane used. The thickness of the hollow fiber membrane used with commercial microdialysis 
probes are 50 µm (including support layer, ~45 µm) and the thickness of the flat PES membrane used for 
the device was ~150 µm. This difference in thickness could increase the resistance of the membrane during 
the experiments reducing the performance of the device. The influence of thickness on the performance of 




The optimal setting for the push-pull experiments was found to be push at 0.2 µL/min and pull at 1.0 µL/min. 
The push-pull results showed that the microfluidic device was able to perform at the same level than 
microdialysis probes without any optimization.  
The relative recovery of methyl orange collected using the microfluidic device was 78.78% ± 2.46% 
(n = 3) and for the microdialysis probes was 89.38% ± 0.91% (n = 3) and 88.29 ± 2.88% (n = 3) for CMA/20 
and CMA/12 respectively. The work shown on this chapter could be the first step into minimizing the need 
for microdialysis calibration methods. The microfluidic device developed for this dissertation could be further 
optimized to achieve the same or better performance as the microdialysis probes in series method. This 
could be done by using a thinner (4 µm) PES membrane for the microfluidic device and increasing the 
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6 Chapter 6.   Conclusions and Future Work 
 
 Conclusions 
The growing interest in developing microdialysis-based microfluidic devices, increasing the 
efficiency (relative recovery) of microdialysis sampling method, and eliminating the microdialysis sampling 
cumbersome and time-consuming calibration methods, were the main factors for the research work 
presented in this dissertation. A new sampling method coined “microdialysis probes in series” was 
developed using microdialysis sampling probes connected in series. The microdialysis probes in series 
method was devised after working with the recycling flow method previously used by several researchers.1-
3 The recycling flow method was described in detail in Chapter 2. The new method improved the efficiency 
of microdialysis sampling by 33% for methyl orange and 2% for FITC-40 when experiments were conducted 
at a pumping rate of 0.8 µL/min. The method was more effective for small molecules such as methyl orange 
(MW = 330 Da), FITC-4 (MW = 4,000 Da), and FITC-10 (MW = 10,000 Da). On the other hand, when larger 
molecules were collected using this method the efficiency was lower. For example, the efficiencies of FITC-
20 (MW = 20,000 Da) and FITC-40 (MW = 40,000 Da) were 4% and 2% respectively when collected at 0.8 
µL/min. The microdialysis sampling probes used for this work had a concentric semi-permeable 
polyethersulfone membrane of 10 mm in length and molecular weight cutoff of 100,000 Da. One of the 
reasons for the lower efficiencies could be that the molecular weight cutoff of the microdialysis probes used 
were either closer or over the recommend values. The Harvard Apparatus Company that makes the 
microdialysis probes used for this work recommend choosing the molecular weight cutoff based on the 
molecular weight of the target analyte. They suggest to use microdialysis probes having membranes with 
molecular weight cutoff of four times the molecular weight of the target analyte.4 This means in order to 
efficiently collect a molecule of 40 kDa, a microdialysis sampling probe having a MWCO of 120 kDa should 
be chosen. However, the FITC-20 or 20 kDa molecule still within the MWCO of the microdialysis sampling 
probe used for this work (100 kDa). Molecular weight cut off alone cannot explain the poor efficiency of the 





A mathematical model based on Bungay’s and Jacobson’s methods was used to estimate how 
many probes in series were necessary to reach equilibrium between the inner and outer concentrations of 
analyte in the microdialysis probes. For small molecules like methyl orange and FITC-4 the model was in 
close agreement with experiments (section 4.2), but for larger molecules like FITC-10, FITC-20, and FITC-
40 the model started deviating from experiments. For instance, the model predicted a relative recovery of 
methyl orange collected using four probes in series at a flow rate of 0.8 µL/min to be 98.8% compared to 
99.7% ± 0.9% obtained experimentally. On the other hand, for the same conditions the relative recovery of 
FITC-40 was predicted to be 21.4% compared to 7.7% ± 0.1% obtained experimentally. However, after 
taking into account the fluid loss the model predictions were in agreement with experiments (Figure 4.7). A 
better understanding of how osmotic, transmembrane, and hydraulic pressures influence the efficiency 
(RR) of the microdialysis probes in series method during collection of molecules, could be valuable to 
develop a microdialysis-based microfluidic device. If the balance of those forces is understood for the 
microdialysis probes in series method, a microfluidic device could be engineering taking advantage of them.  
The microdialysis probes in series method was miniaturized into a PDMS microfluidic device. This 
microdialysis-based microfluidic system was able to mimic a regular microdialysis probes efficiency under 
certain conditions (e.g., push-pull). For example, the collections conducted at a pushing rate of 0.2 µL/min 
and pulling rate of 1.0 µL/min using methyl orange as analyte were 78.8% ± 2.5%, 88.3% ± 2.9%, and 
89.4% ± 0.9% using the microdialysis-based microfluidic system, CMA/12, and CMA/20 microdialysis 
probes respectively. These results indicated that the microdialysis-based microfluidic device needs further 
optimization.   
 Future Work 
One of the future work that could be done to elucidate the poor efficiency of the microdialysis 
sampling probes in series for large molecules is to study different compounds with uniform radius of gyration 
and different molecule weights. This would minimize the influence of the molecular conformation during the 
experiments. More experiments should to be done using the microdialysis probes in series method. One of 
the experiments that should be done is an experiment placing each microdialysis sampling probe in series 




This experiment would show the contribution of each connection to fluid loss or how much pressure is 
generated at each point. As mentioned before in Chapter 1 section 1.5.2.2, several researcher have devised 
methods to systematically regulate the pressure inside and outside of a microdialysis sampling probe to 
find optimal conditions, see Figure 1.15.5 However, as far as this author knows, the same type of 
experiments have not be done using microdialysis probes in series. A similar experiment like Chu et al. 
could be performed using their chamber, but connecting four microdialysis probes in series. For their work, 
they did not connect each probe in series. Using a chamber like the one show on Figure 1.15 would simplify 
the study of how the osmotic, transmembrane, and hydraulic pressures influence the relative recovery of 
molecules. This would lead to the optimal conditions of the microdialysis probes in series for different 
molecules. The work done by Chu et al. showed how those forces influenced the relative recovery of one 
microdialysis probes. The information obtained about those forces during microdialysis probes in series, 
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